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The focus of this work was to develop a homogeneous assay for sigma-binding to E. 
coli core RNA polymerase and a fragment of the β'-subunit of the core based on 
luminescence resonance energy transfer (LRET). The technical advances offered by LRET 
through the use of long-lived lanthanide fluorophores resulted in a very robust assay suitable 
for biochemical characterization and high-throughput screening. With this assay I was able to 
obtain binding constants for the sigma-core interaction. It was also used to screen a small 
crude natural product library consisting of extracts from marine sponges. One of these 
samples was found active in this screen and was validated to inhibit transcription by in vitro 
transcription assays. 
Furthermore a mouse hybridoma cell line was created that produces a monoclonal 
antibody (8RB13) that binds selectively to core RNA polymerase from many different 
bacteria. Since this antibody was also selected for polyol sensitivity, i.e. it releases its antigen 
under very gentle conditions (40% 1,2-propanediol and 700 mM ammonium sulfate), it 
allows a rapid and efficient purification of RNA polymerase by immunoaffinity 
chromatography. Active core enzyme was purified from E. coli, B. subtilis, P. aeruginosa 
and S. coelicolor. 
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A significant part of this work was to optimize techniques for fluorescence labeling of 
proteins. A fast and convenient way for fluorescence labeling of recombinant proteins was 
developed combining purification and on-column derivatization. As a further result of the 
fluorescence labeling studies, a fast protocol for qualitative and quantitative Western blots 
using fluorescence labeled primary antibodies was established. By the use of IC5-labeled 
primary Mabs, a secondary antibody and an enzyme-catalyzed signal producing reaction is no 
longer needed, which reduces the procedure time, starting from a blocked membrane, to less 
than 75 minutes for quantitative measurements. Depending on the size of the antigen, I 
obtained a linear working range over more than two orders of magnitude of measured protein 
within the range from 1 to 1000 ng. 
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Zusammenfassung 
Das Ziel dieser Arbeit war es einen homogenen Assay basierend auf Lumineszens 
Resonanz Energie Transfer (LRET) für das Binden des Sigmafaktors an core RNA 
Polymerase von E. coli und an ein Fragment der β'-Untereinheit des core Enzyms zu 
entwickeln. Dabei resultierten die technischen Vorteile von LRET, hervorgehend aus einer 
langlebigen Lanthanid-Lumineszens, in einem äußerst robusten Assay, der sich zur 
biochemischen Charakterisierung der untersuchten Proteine und zu einem Hochdurchsatz 
Screening von Wirkstoffbibliotheken nach potentiellen Inhibitoren dieser Protein-Protein 
Wechselwirkung eignet. Mit Hilfe dieses Assays war es möglich, Bindekonstanten für die 
Interaktion zwischen σ70 und σ32 und core RNA Polymerase zu messen. Daraufhin wurde 
eine kleine Naturstoffbibliothek bestehend aus Extrakten von marinen Schwämmen auf 
Inhibitoren untersucht, und es konnte eine positive Probe gefunden und in vitro dessen 
inhibitiorische Wirkung auf die transkriptionelle Aktivität der RNA Polymerase bestätigt 
werden. 
Zudem konnte eine Hybridoma Zellinie hergestellt und isoliert werden, die einen 
monoklonalen Antikörper (8RB13) sekretiert, welcher selektiv an core RNA Polymerase 
verschiedenen bakteriellen Ursprungs bindet. Da dieser Antikörper auf Polyolsensitivität hin 
selektiert wurde, welches ein Ablösen des Antigens unter sehr schonenden Bedingungen 
(40% 1,2-Propandiol und 700 mM Ammoniumsufat) ermöglicht, kann er zur raschen und 
effizienten Aufreinigung von core RNA Polymerase mittels 
Immunoaffinitätschromatographie eingesetzt werden. Auf diesem Wege wurden aktive RNA 
Polymerasen aus E. coli, B. subtilis, P. aeruginosa und S. coelicolor aufgereinigt. 
Ein Großteil dieser Arbeit konzentrierte sich auf die Optimierung von Techniken zur 
effektiven Fluoreszensmarkierung von Proteinen. Daraus resultierte die Entwicklung eines 
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schnellen und leicht durchführbaren Verfahrens zur Fluoreszensmarkierung von 
rekombinanten Proteinen in Form einer Derivatisierung des Proteins in säulengebundener 
Form. Ebenso wurde ein verbessertes Protokoll für eine schnelle qualitative und quantitative 
Auswertung von Western Blots entwickelt. Durch die Verwendung von 
fluoreszensmarkierten primären Antikörpern kann auf die Verwendung eines sekundären 
Antikörpers und die daran gekoppelte Enzym katalysierte Farbreaktion verzichtet werden, 
welche in den gängigen Methoden ein verstärktes Signal erzeugt. Das hierzu benutzte 
Protokoll verringert die Gesamtzeit, die für einen Western Blot benötigt wird, auf weniger als 
75 Minuten für quantitative Messungen, nach Transfer auf eine Nitrocellulose Membran. Es 
wurde ein linearer Anwendungsbereich von mehr als zwei Größenordnungen erreicht, der 
sich abhängig von der Größe des untersuchten Proteins von 1 bis 1000 ng erstreckte. 
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Chapter 1 
 
Introduction 
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1.1 Characterization of protein-protein interactions 
Great interest lies in the identification and characterization of protein-protein 
interactions. While amino acid sequence, structure and catalytic activity can provide valuable 
information about the function of a protein, the knowledge about its binding partners and the 
nature of their interactions is necessary for a more detailed understanding of its role within an 
organism. It will also be crucial for identifying the function of many hypothetical proteins 
found by a growing number of genomic sequencing projects. Many processes like cell 
signaling, metabolism, enzymatic activity and specificity are controlled by modulation of 
their structure and function upon binding of two or more proteins. Only if we can combine 
this information, can we begin to comprehend the organization and regulation of cellular 
processes, and eventually manipulate and harness these processes for their use in 
biotechnology, pharmacology, agriculture and research. 
 
1.2 Transcription and its regulation 
Transcriptional regulation is an example of a process that is mediated significantly by 
protein-protein interactions since binding of transcription factors to RNA polymerase confer 
its binding specificity for promoters of transcribed genes (1, 2). After DNA-directed RNA 
polymerase is directed to a specific site on the DNA, it is able to melt the DNA and start 
transcription by synthesizing RNA in 5' to 3' direction using one strand of the DNA as a 
template. Transcription factors are involved in melting the DNA, initiation, activation or 
repression, elongation and termination. 
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1.2.1 E. coli RNA polymerase 
A model system for bacterial RNA polymerases is the E. coli enzyme. The core 
enzyme consists of two α subunits (RpoA, 36.5 kDa), one β subunit (RpoB, 151 kDa), one β' 
subunit (RpoC, 155 kDa) and one ω subunit (RpoZ, 10 kDa) (3). It can bind DNA non-
specifically and initiate transcription from single-stranded DNA and free DNA ends. The 
holo form of RNA polymerase contains core enzyme plus a sigma factor. It specifically binds 
DNA-sequences at recognized promoters with significantly higher affinity and is then able to 
initiate transcription from double-stranded DNA. Sigma factors belong to the family of 
prokaryotic transcription factors that globally regulate gene expression under different 
conditions and for large sets of genes. Recognized promoter sites share consensus sequences 
usually centered around bases -10 and -35 relative to the transcription start site at base +1 and 
are characteristic for each individual sigma factor. That way a sigma factor can regulate sets 
of genes controlled by promoters that fall within the corresponding consensus sequence. The 
affinity for the holoenzyme and therefore the strength of a promoter is governed by its 
equivalency to the consensus sequence. E. coli possesses seven sigma factors which are 
summarized in Table 1.1 (4-8). 
 
Table 1.1: Summary of E. coli sigma factors. The gene, size, recognized consensus sequence and the 
classes of genes that are regulated are indicated for each of the seven E. coli sigma factors. 
Factor 
 
Gene Size (kDa) Consensus Binding Site Genes Regulated 
σ70 (σD) rpoD 70    TTGACA-N17-TATAAT Housekeeping 
σ54 (σN) rpoN (ntrA) 54  CTGGCAC-N5-TTGCA Nitrogen metabolism 
σS rpoS (katF) 38     TTGACA-N12-TGTGCTATACT Stationary phase 
σ32 (σH) rpoH (htpR) 32     CTTGAA-N14-CCCCATNT Heat shock 
σF (σ28) fliA 28          TAAA-N15-GCCGATAA Flagellar proteins 
σE rpoE 24     GAACTT-N16-TCTGA Extreme heat shock 
σfecI fecI 19     GGAAAT-N17-TC Iron transport 
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The protein levels of sigma factors in the cell are tightly regulated and vary with the 
physiological growth conditions and the environment (9). The major sigma factor, σ70, is 
present at all times and recognizes the majority of promoters in the cell. It is responsible for 
the transcription of the genes that are required for the general survival of the cell and is 
therefore termed the housekeeping sigma. σS is responsible for transcription of the genes in 
stationary phase (10, 11) and is therefore most abundant during this period of the growth 
cycle whereas its expression level is otherwise very low. Unlike other bacteria, E. coli does 
not sporulate when it encounters low levels of nutrients. Instead it turns into a quiescent form 
mainly regulated by σS that reduces the expression of essential genes to a minimum until 
nutrient conditions have improved. σF regulates the transcription of flagellar biosynthesis 
genes. σ32 and σE are both involved in heat shock response (7, 12). σFecI regulates genes 
involved in the citrate dependent iron transport into the cell (13) and together with σE belongs 
to the family of extracytoplasmic function (ECF) sigma factors. This means that both are 
localized at the inner membrane of the cell and respond to extracytoplasmic signals. σ54 
regulates genes in response to nitrogen starvation and is the most different among the sigma 
factors (14, 15). For example it recognizes promoters at position -12 and -24 and unlike the 
other sigma factors, is capable of binding DNA on its own. The other sigma factors have to 
be bound to core RNA polymerase in order to bind their promoter recognition sequence. Thus 
σ54  does not belong to the σ70 family unlike all the other sigmas. 
 
1.2.2 Structural characteristics of sigma factors and core RNA polymerase from E. coli 
Although the size of the sigma factors varies significantly, they share four regions 
highly conserved within the σ70-family (Figure 1.1).  
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Figure 1.1: Schematic illustration of the sub-domain structures in σ70 and their assigned functions (2). 
Regions of initial contacts to core are indicated at the bottom. The size and position of the regions are 
indicated by the amino acid residues. 
 
Region 1 is known to interact with core. The N-terminal region 1.1 is only present in 
the primary sigma factors σ70 and σS and it has been shown to mask DNA binding sites of 
sigma by interacting with region 4 (16, 17). Region 2 contains the main site responsible for 
sigma binding to core RNA polymerase and is also the most conserved among the σ70-family 
(2). It also binds specifically to single-stranded DNA in the -10 binding region of the 
promoter consensus region. Mutations in region 3 show defects in initiation of transcription. 
Region 4 is responsible for the contact to the -35 promoter site on the DNA. Although 
contacts of all four regions of σ70 to core RNA polymerase have been found, there is evidence 
for the fact that region 2 contains the most important binding site, that establishes 
incorporation of sigma into holo RNA polymerase. Single residue mutations in the region 2 
have been shown to knock out binding to core and were lethal to the cell. Electrophoretic 
mobility shift assays have supported these results in vitro (18). 
The crystal structure for RNA polymerase σ70 subunit from E. coli is available only 
for a protease-resistant fragment of σ70 lacking region 3, 4 and region 1.1 (19). However the 
crystal structures of core and holoenzyme were solved recently, but only for the evolutionary-
Initial Core
Contacts
-10 recognition –35 recognition
1.1 1.2 3.1 3.2 4.1 4.22.1 2.32.4 2.52.2
nonc onse rved region Region
Functioninhibits σ-DNA binding
c
ssDNA binding       activation
100             200            300      400               500          600
|              |                 |        |                    |               |
β 900-909 β´ 260-309 β 1060-1240
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related Thermus aquaticus (20) and Thermus thermophilus (21). Among many insights into 
structural and functional features of the enzyme that have been studied for decades with low 
resolution methods, these structures confirmed the interaction sites for sigma to core RNA 
polymerase previously suggested by Arthur et al. (22) and Sharp et al. (18) (Figure 1.2). 
Figure 1.2: Structure of holo RNA polymerase from T. thermophilus(21). The subunits are colored σ 
white, β' red, β blue, α green and light yellow. The interaction partner of region 2 of σ contacts the coiled-
coil in β' (shown in yellow). 
 
The key interaction site consists of a coiled-coil corresponding to residues 260-309 
within the E. coli β' subunit (22, 23). This region was identified by the use of Far-Western 
blot analysis and the use of an ordered fragment ladder of the β' subunit. Far-Western blot 
analysis is performed similar to regular Western blot procedures with the exception that a 
radioactively labeled protein (in this case σ70) is used instead of an antibody to probe the blot. 
The SDS-PAGE gel for the blot was prepared with purified His6-tagged fragments of the β' 
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subunit that set up a ladder on the gel which allowed assessment of the regions necessary for 
binding σ70. Additionally these fragments were immobilized on a Ni-NTA resin and tested 
for their ability to bind σ70. These investigations and some of the material from the work of 
T. Arthur were the basis of the binding studies of sigma to the β' subunit of core RNA 
polymerase described in this thesis. 
In the β' subunit, the coiled coil sticks out like a landing pad for sigma. Region 2 
corresponding to residues 360-421 in σ70, interacts mainly through ionic interactions with 
that region which were independently found through computer docking analysis by Burgess 
and Anthony (2). This could explain the negative effect of salt on the binding at this interface 
that has been known since the first identification of sigma in 1969 by R.R. Burgess (3, 24). 
 
1.2.3 RNA polymerases from other bacteria 
As mentioned before, there is homology among bacterial RNA polymerases, allowing 
one to draw conclusions from X-ray crystal structures to homologues from other bacteria. 
The five subunits of core RNA polymerases are highly conserved among all known 
eubacterial species although they can vary slightly in size. The sigma factors are also highly 
conserved in Eubacteria. The level of conservation in region 2 of the σ70 family, responsible 
for binding core RNA polymerase, is remarkably high and many sigma factors have been 
identified by their sequence due to this homology. The number of sigmas factors varies 
significantly. While E. coli manages to get along with 7 sigma factors, other species like 
Mycoplasma genitalium have to live with only one sigma factor (25) whereas Streptomyces 
coelicolor so far holds the record of all sequenced bacterial genomes with 65 different sigma 
factors (26). Table 1.2 shows a list of bacteria and their repertoire of sigma factors (27). 
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Table 1.2: Number of sigma factors from a variety of bacterial species (27) 
Organism free living 
Total number of 
sigma factors 
# of sigma factors 
in the σ 70 famiy 
# of sigma factors 
in the σ 54 famiy 
# of ECF 
sigma factors 
 
B. subtilis yes 18 10 1 7 
E. coli yes 7 4 1 2 
Heamophilus influenza no 4 2 0 2 
Mycobacterium tuberculosis yes 13 3 0 10 
Mycoplasma genitalium no 1 1 0 0 
Pseudomonas aeruginosa yes 24 24 1 19 
S. aureus yes 3 3 0 0 
S. coelicolor yes 65 6 14 45 
 
As a common pattern it was found that free-living species generally have a higher 
number of sigma factors both from the ECF and the σ70 family due to their need for a more 
complex transcriptional regulatory pattern, that allows them to adjust to marginal changes in 
their environment. Many of these are involved in the regulation of pathogen and antibiotic 
biosynthesis and are therefore especially of pharmacological interest. 
1.2.4 Eukaryotic RNA polymerase II - the bacterial counterpart 
The mRNA in eukaryotic cells is synthesized by eukaryotic RNA polymerase II (Pol 
II). Mechanisms in eukaryotic transcriptions are of much greater complexity and far less 
thoroughly understood and much can be learned from studying their bacterial counterpart. 
However there is enough similarity between these two enzymes, that the corresponding 
subunits of bacterial RNA polymerase can be assigned as homologues to some of the known 
subunits in PolII. Partially these homologies are based on structure rather than sequence 
similarities. An overview of the core subunits in Pol II and its corresponding homologues in 
E. coli RNA polymerase is shown in Figure 1.3. 
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Figure 1.3: Homologous subunits in RNA polymerases from E. coli and S. cerevisiae. The four subunits of 
E. coli core RNA polymerase are shown on the left and their homologues in S. cerevisiae RNAP II to the 
right. The lines indicate homologous subunits. Note that there are no known sigma homologues in 
eukaryotic cells. S indicates subunits that are shared between RNAP I (synthesis of rRNA), RNAP II 
(synthesis of mRNA) and RNAP III (synthesis of tRNA and other small RNAs). 
1.2.5 Bacterial RNA polymerases as a target for drug discovery  
The demand for new antimicrobial drugs is becoming increasingly urgent, since 
resistance mechanisms against whole classes of antibiotics are currently developing faster 
than research generates new structurally-different agents. Proteins involved in the central 
processes of the life cycle of a cell like replication, transcription, translation and cell wall 
biosynthesis have been traditionally exploited for drug discovery. As the key enzymes 
involved in these essential processes, DNA polymerase, the ribosome and the transcription 
machinery offer attractive targets for inhibitor screening. An important issue for the use of 
such an inhibitor as a drug in clinical applications is that the target site of the drug be absent 
in human cells. 
α
β
β '
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The interface between sigma and core RNA polymerase offers such an attractive 
target, since no sigma homologue has been found in archaea and mammalian cells except for 
sigma factors in mitochondria (28) and chloroplasts (29). However, they do not show a 
significant homology to bacterial sigma factors. This fact implies that there is very little 
chance of a potential new antibiotic interfering with eukaryotic RNAP assembly, which could 
otherwise lead to serious side effects if it were used as a drug. Any inhibitor of sigma-core 
interaction should inhibit the initiation of transcription and should therefore act as a 
bacteriostatic agent. This is supported by the fact that induction of expression of the β'-
coiled-coil fragment (residues 260-309) stops cell growth in E. coli (30). Although numerous 
antibiotics are known to inhibit transcription, none is known to interact either with region 2 of 
sigma or with the coiled-coil of the β' subunit of core. This offers the potential for a new class 
of antibiotics with a low initial occurrence of resistance. On the same note one could expect, 
that it would challenge the organism massively to develop resistance-conferring mutations in 
this site, since it is expected to interact with most of the sigma factors, which cannot be 
compromised in their affinity to that site by such a mutation. The homologies among 
different bacterial sigma factors and the coiled-coil in the β'-subunit suggest that any inhibitor 
of this interaction might lead to a broad-spectrum antibiotic. A sequence alignment of the 
coiled-coil in the β' subunit from several bacterial species as well as its human homologue is 
shown in Figure 1.4 (2). 
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Figure 1.4: Alignment of sequences from the coiled-coil in the β'-subunit. Sequences from E. coli, 
Haemophilus influenzae, Staphylococcus aureus, B. subtilis, Borrelia burgdorferi, Mycobacterium 
tuberculosis and Thermus aquaticus comprising the residues from the coiled-coil in the β'-subunit that is 
crucial for sigma binding. For comparison, the sequence of the structurally conserved coiled-coil from 
human RpbI is shown at the bottom. The schematic illustration of the α-helices within this region is 
shown above the sequences. 
 
1.3 Methods to study protein-protein interactions 
Several techniques are commonly used in order to study protein-protein interactions. 
These can be divided into homogeneous, i.e. studying the binding partners while they are free 
in solution and inhomogeneous if one or more of the binding components are bound to a 
matrix or must be separated before they are analyzed. Crucial to inhomogeneous methods is 
that they often result in a change of the equilibrium conditions at which initial binding occurs. 
Procedures that involve immobilization often perturb the structure of the immobilized protein 
or the chemical environment during the binding event. Separating the complex from the 
unbound binding partner (either by size, charge, hydrophobicity or other physical properties) 
perturb the equilibrium and thus weak interactions (i.e., complexes that have a half life 
shorter than the time scale of the separation step are underrepresented or cannot be detected 
since the interaction doesn't persist throughout the procedure). This is true for all non-
homogenous techniques like surface plasmon resonance (SPR, used in BIAcore instruments), 
co-immunoprecipitation or "pull-down" assays, ELISA assays, Far-Western blotting, affinity 
E. coli
H. influenza
S. aureus
B. subtilis
M. tuberculosis
T. aquaticus
H. sapiens
265                   284                      292                        309
Helix Helix
FATSDLNDLYRRVINRNNRLKRLLDLAAPDIIVRNEKRMLQEAVDALLDN
FATSDLNDLYRRVINRNNRLKRLLDLIAPDIIVRNEKRMLQESVDALLDN
FATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDN
FATSDLNDLYRRVINRNNRLKRLLDLGAPSIIVQNEKRMLQEAVDALIDN
FATSDLNDLYRRVINRNNRLKRLIDLGAPEIIVNNEKRMLQESVDALFDN
FATSDLNDLYRRLINRNNRLKKLLAQGAPEIIIRNERRMLQEAVDAVIDN
RNQDDLTHKLADIVKINNQLRRNEQNGAAAHVIAEDVKLLQFHVATMVDN
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chromatography, as well as size exclusion chromatography and sucrose gradient 
centrifugation. 
In homogeneous techniques, all components of the assay are free in solution and no 
separation steps are used. A key benefit of such an assay is that the binding measurement is 
done without perturbing the binding equilibrium. This often allows more accurate assessment 
of the binding forces and mechanisms present. In most cases it is the superior technique, 
although technically more demanding. Many homogeneous techniques involve spectroscopic 
methods because the use of light as a probe doesn't change the conditions in most systems. 
These methods use NMR, light scattering, and very often fluorescent probes like in 
fluorescence polarization (FP) and fluorescence resonance energy transfer (FRET) assays. 
Recent developments of FRET also allow analysis of protein-protein interactions in vivo (31). 
Its close relative luminescence resonance energy transfer (LRET) makes use of luminescent 
lanthanide derivatives. LRET allows a remarkable reduction of the measured background 
fluorescence due to the enhanced fluorescence halflives of these luminescent probes like 
europium (1 ms) and terbium (2 ms). Most organic dyes have fluorescence lifetimes of less 
than 1 ns and decay by the time emission signals are acquired in a typical LRET experiment 
(50 to 400 µs). The key mechanism in these techniques is a radiationless energy transfer due 
to dipole-dipole interactions at resonance conditions. These occur if two suitable dyes come 
within a distance of less than 10 nm and decay due to their nature with the inverse sixths 
power of their distance. Measuring the emission of the donor and acceptor fluorophores gives 
information about the extent of the energy transfer and allows monitoring the distance of two 
fluorescence-labeled proteins within these dimensions and more generally whether two 
proteins are bound to each other or not. The theory and principles of are described in Chapter 
3 "LRET-Based High-Throughput Screening Assay for Inhibitors of Essential Protein-Protein 
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Interactions in Bacterial RNA Polymerase". Together with two-hybrid screens and functional 
assays these are currently the only established methods to obtain reliable in vivo data. 
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1.4 Thesis Plan 
The goal of this thesis was to develop a homogenous assay for sigma-binding to core 
RNA polymerase from E. coli by LRET and to investigate its use as a high-throughput screen 
for inhibitors of this protein-protein interaction. 
Chapter 2 describes a rapid and efficient fluorescence-labeling procedure for proteins 
that includes TCEP-mediated reduction prior to cysteine-directed labeling and subsequent 
dye removal while the protein is bound to a resin for purification. This was necessary to 
achieve a maximum fluorescence-labeling efficiency of proteins for their use in LRET 
assays. It was crucial to efficiently remove free dye since it can cause diffusion-controlled 
LRET leading to false signals in the assay. 
Chapter 3 outlines the development of a homogeneous LRET-based assay for sigma-
binding to its major binding site in the β' subunit of core RNA polymerase from E. coli. It 
contains the IC5-labeled fragment (residues 100 to 309) of the β' subunit and a single 
cysteine mutant of σ70 labeled with an Eu-chelate. The use of the assay for high-throughput 
screening was evaluated and an initial screen of a small natural product library isolated from 
marine sponges for inhibitors of sigma-binding to core RNA polymerase was performed. 
Chapter 4 reports the initial results of a further developed LRET-assay using the full 
length core RNA polymerase randomly labeled through lysine residues with IC3-succinimide 
and σ70 or σ32 randomly labeled through lysine residues with cs124-Tb-TTHA-NSC. The 
goal of this Chapter was to use the LRET-assay to derive equilibrium binding constants for 
sigma binding to core RNA polymerase. 
Chapter 5 describes the making of a monoclonal antibody 8RB13 with a high cross-
reactivity for RNA polymerases from different bacterial species and its performance in 
immunoaffinity chromatography. The purification of active core RNA polymerase from E. 
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coli, B. subtilis, S. coelicolor and P. aeruginosa was done to confirm its utility in protein 
purification. This project was conducted mainly for my own educational purposes, although it 
turned out to be a powerful tool for getting access to a diversity of RNA polymerases and 
their future characterization with the LRET-based binding assay. 
Chapter 6 summarizes the efforts to use fluorescence-labeled antibodies in 
quantitative Western blots. The goal was to get a reliable tool to measure protein levels of 
sigma factors in crude cell extracts from Ε. coli that could later be used for in vivo studies of 
sigma competition for core RNA polymerase. 
The Appendix contains a summary of methods and results already outlined in 
Chapters 2 and 3 in the form of protocols and was added to this thesis only for the convenient 
use of the described methods in the laboratory. 
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Chapter 2 
 
On-column TCEP Reduction and IC5-Maleimide Labeling During 
Purification of a RpoC-Fragment on a Ni-NTA Column 
 
 
 
This Chapter has been published as: 
Bergendahl, V., Anthony, L. C., Heyduk, T., and Burgess, R. R. (2002) On-column tris(2-
carboxyethyl)phosphine reduction and IC5-maleimide labeling during purification of a RpoC 
fragment on a nickel–nitrilotriacetic acid column. Anal Biochem 307, 368. 
 
My contributions are that I performed all the experiments and wrote the manuscript. Larry C. 
Anthony introduced me into the protein purification methods for σ70 and the β'-fragment. 
Tomasz Heyduk provided the Europium label used in this study. 
 
R. R. Burgess is the principal investigator. 
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2.1 Summary 
Fluorescence labeling of proteins has become increasingly important since fluorescent 
techniques like FRET and fluorescence polarization are now commonly used in protein 
binding studies, proteomics, and for high-throughput screening in drug discovery. In our 
efforts to study the binding of the β'-subunit from E. coli RNA polymerase (RNAP) to σ70, 
we synthesized a fluorescent-labeled β’-fragment (residues 100-309) in a very convenient 
way, that could be used as a general protocol for hexahistidine-tagged proteins. By 
performing all the following steps, purification, reduction, derivatization with IC5-
maleimide, and free dye removal while the protein was bound to the column, we were able to 
reduce the procedure time significantly and at the same time achieve better labeling 
efficiency and quality. The β'-fragment with a C-terminal His6-tag was purified from 
inclusion bodies and could be refolded prior to or after binding to a Ni-NTA affinity column. 
Reduction prior to labeling was achieved with TCEP that does not interfere with Ni-NTA 
chemistry. The labeled β'-fragment was tested with σ70 that was labeled with an Europium-
based fluorophore for binding in a electrophoretic mobility shift assay. The sigma-to-core 
protein interaction in bacterial RNA polymerase offers a potentially specific target for drug 
discovery, since it is highly conserved among the eubacteria, but differs significantly from 
eukaryotes. 
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2.2 Introduction 
Fluorescence-based assays play an important role in biochemistry and molecular 
biology, due to their sensitivity and versatility in studying the properties of nucleic acids and 
proteins (1-3). Although the physical properties of fluorophores and chemical tools for 
derivatization of selective functional groups in the target molecules have been well known for 
more than 20 years, the integration of this knowledge into established biochemical techniques 
has just begun. The requirements for the almost exclusively aqueous biochemical or 
physiological assays like salt, pH, reducing agents and temperature are typically different 
from the conditions in which these compounds and reactions were originally studied. 
Nevertheless, it is very often possible to combine common biological and biochemical 
techniques with the conditions required for coupling fluorescent dyes to functional groups 
like amines, phosphates, sugars, sulfhydryl and carboxyl groups, which are abundant in 
proteins and nucleic acids. In this work we present an example of how an efficient labeling 
procedure can be integrated into the currently very popular IMAC protein purification 
method (4) using Ni-NTA resin (5). The benefit of this combined approach over performing 
purification and labeling separately is a clearly shorter and more efficient procedure. Excess 
dye and byproducts can be washed away from the final product, while the target protein is 
still bound to the column matrix during purification. 
The bacterial transcription machinery appears to offer an attractive target for drug 
discovery and drug design. In that respect we decided to study the assembly of the major 
sigma factor σ70 with core RNAP to form the holoenzyme by the use of fluorescent probes. 
The postulated region mainly responsible for core binding (region 2.1-2.2, Figure 2.1) of 
bacterial transcription factors (σ70 in E. coli) shows remarkable sequence identity (>80%) 
among the major sigma factors and is also conserved among the minor sigma factors of 
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bacteria (6, 7). Additionally their binding partner β' (Figure 2.1) in core RNAP exhibits a 
very high sequence conservation in the previously identified sigma-binding region (between 
residues 260-309 in the β'-subunit of E. coli) (8, 9).  
 
 
Figure 2.1: Structures of the β'-fragment (A) and σ70 (B) that are the targets for the protein binding 
assay. Next to the names are the mutations and the derivatization sites (indicated by white letters). HMK-
His6-β'-100-309 indicates that the fragment of β' contains residues 100-309 and is a N-terminal fusion to a 
heart-muscle kinase (HMK) recognition site and a His6-tag. The structure was taken from (10). The 
coiled-coil α-helical structure colored black in the β'-fragment is thought to be a primary sigma binding 
element in the RNAP (9). The regions in σ70 responsible for binding to the β'-contact region of core 
RNAP are regions 2.1 (green) and 2.2 (yellow). Regions 2.3 and 2.4 are indicated in blue and brown, 
respectively. The non-conserved region is in white. The structure was taken from (11). The labels IC5 on 
the β'-fragment and Eu-DTPA-AMCA on σ70 are also indicated in black in their expected positions. 
 
These homologies suggest a highly conserved structure within the holoenzyme form 
of RNAP, whose formation is crucial for a correct initiation of transcription. Any inhibitor of 
this protein-protein interaction can thus be expected to be a broad-spectrum antibiotic 
candidate. No σ70 homologue has been found in mammalian cells except for sigma factors in 
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mitochondria (12) and chloroplasts (13). However, these sigma factors do not show strong 
similarity to their prokaryotic counterparts. This implies that there is very little chance of a 
potential new antibiotic interfering with eukaryotic RNA polymerase assembly leading to 
serious side effects if it were used as a drug. 
 In order to screen for inhibitors of RNAP assembly with sigma, a simple, fast 
and reliable assay had to be found for the formation of the σ70-β'-complex. We have chosen 
to use LRET (Luminescence Resonance Energy Transfer) a recent modification of FRET, 
that can create the desired signal upon complex formation (14-16). The more general term 
luminescence instead of fluorescence (as in FRET) indicates that lanthanide emission is 
technically not fluorescence (i.e. arising from a singlet to singlet transition) (17). Differences 
in the physical processes result in different fluorescent lifetimes of the lanthanide-based 
donor fluorophore (> microseconds up to several milliseconds) compared to the short lifetime 
of most organic-based fluorophores in FRET (picoseconds up to a microsecond). The 
conventional dipole-dipole theory of Förster is still applicable for LRET, so that the 
difference of the two lies mainly in the technical advantages offered by LRET (15). Heyduk 
and co-workers have used a Europium-chelate fluorophore to measure DNA binding to σ70 
in holoenzyme using the same pair of dyes (18). They have been able to show its applicability 
within this system. We adapted their procedure to synthesize IC5-labeled β'-fragment 
(residues 100-309 with a His6-tag followed by a heart-muscle kinase (HMK) recognition site 
fused to the N-terminus) and integrated it into our current purification protocol. For the 
desired homogenous assay, we labeled σ70 with a Europium-DTPA-AMCA complex as a 
donor as described by Heyduk et al (18). The structures of the dyes are shown in figure 2.2. 
We tested the labeled proteins for their binding activity with native PAGE gels in 
electrophoretic mobility shift assays. 
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Figure 2.2: The fluorophores that were used to derivatize the proteins. The Eu-chelate DTPA-AMCA-
maleimide was used to label sigma70. IC5-PE-maleimide served as the label for the β'-fragment. 
 
Controlled labeling of proteins with only one fluorophore can be performed by 
exploiting the specificity of maleimide-linked dyes with cysteine residues (19). For uniform 
labeling it is desirable that the protein has only one cysteine residue. The maleimide moiety 
of the label usually reacts readily in most buffers used in biochemistry and is highly specific 
to sulfhydryl residues at pH-values below 7.5 (20). However oligomerization and oxidation 
of the sample can lead to a significant loss of labeling. Getz et al. (21) have found that any 
reducing agents such as 2-ME and TCEP (22) can inhibit maleimide labeling significantly, so 
that their presence during the labeling reaction is undesirable. Another challenge when 
labeling proteins is the separation of labeled product from the excess dye. This is especially 
important for samples used in FRET and LRET assays, since too much free dye can cause 
additional signal by diffusion-controlled resonance energy transfer when working at 
concentrations above 100 nM. For cyanine dyes like IC5 it very difficult to remove excess 
dye by dialysis and usually requires an extra gel filtration step. In our system, we tried to 
combine all steps by working on a Ni-NTA column throughout containing a hexahistidine-
tagged beta prime (RpoC) fragment (residues 100-309), that has a single naturally-occurring 
cysteine at residue 198. We circumvented reducing the Ni-resin by using TCEP instead of 2-
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ME. After reduction, TCEP was washed away and the on-column derivatization was carried 
out immediately to avoid oxidation. Excess dye could be washed from the column while the 
labeled product remained bound to the resin. Since we started with purified inclusion bodies, 
we tested refolding before IMAC and on-column before and after labeling. 
2.3 Experimental procedures 
2.3.1 Materials and chemicals 
IC5-PE-maleimide was purchased from Dojindo Molecular Technologies, Inc. 
(Gaithersburg, USA). DTPA-AMCA-maleimide was produced as described (18) by T. 
Heyduk. (CAS numbers of the used starting materials: DTPA-anhydride: 23911-26-4, 
Maleimido-propionic acid, NHS ester: 55750-62-4, AMCA: 106562-32-7). The identity of 
AMCA-DTPA-maleimide was established by its spectroscopic properties (ability to sensitize 
Europium; blue-shifted emission and absorption of AMCA moiety which is characteristic of 
reaction of its 7-amino group), its ability to react with thiols and by mass spectrometry. A 
single peak on reverse phase HPLC was taken as an indication of the purity of AMCA-
DTPA-maleimide (data not shown). Ni-NTA resin was purchased at Qiagen. TCEP and 
TritonX-100 were purchased at Pierce. EuCl3 and all other chemicals were purchased from 
Sigma unless otherwise indicated in the text. 
2.3.2 Buffers 
NTG buffer: 50 mM NaCl, 50 mM Tris-HCl, pH 7.5, 5 % glycerol; NTGED buffer: 
50 mM NaCl, 50 mM Tris-HCl, pH 7.5, 5 % glycerol, 0.1 mM EDTA, 0.1 mM DTT; TGE 
buffer: 50 mM Tris-HCl, pH 7.5, 5 % glycerol, 0.1 mM EDTA; NTTwGu buffer: 500 mM 
NaCl, 50 mM Tris-HCl, pH 7.5, 0.1 %Tween 20, 6 M Gu-HCl; NTTw buffer: 500 mM NaCl, 
50 mM Tris-HCl, pH 7.5, 0.1 %Tween 20; Storage buffer: 50 mM, 200 mM Tris-HCl, pH 
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7.5, 50 % glycerol, 0.5 mM EDTA, 0.1 mM DTT; Native buffer: 200 mM Tris-HCl, pH 7.5, 
20 % glycerol, 0.005 % Bromphenol blue 
 
2.3.3 Overproduction of HMK-His6-β'(100-309) and σ70 (S442C) 
HMK-His6-β'(100-309) was overproduced from pTA133 (9) and is a chimera (25 
kDa) with the amino acid sequence MARRASVHHHHHHM N-terminally fused to β'(100-
309). The underlined sequence represents a heart muscle kinase (HMK) recognition site and 
was used in the original construct to allow 32P-labeling of the protein (23), but we did not 
make use of it in this paper. Sigma70(442C) is overproduced from a plasmid (18) derived 
from the σ70-expression system pGEMD (24, 25) that had a HindIII fragment containing the 
rpoD gene from E. coli cloned into a pGEMX-1 (Promega) vector. Both are T7 expression 
systems allowing controlled induction by IPTG and selection with ampicillin. The plasmids 
were transformed into BL21(DE3) (Novagen) for expression. The cells were grown in 1-L 
cultures at 37°C in LB medium with 100 µg/ml ampicillin. The cultures were grown to an 
OD600 between 0.5-0.7 and then induced with 0.5 mM isopropyl β-D-thiogalactoside (IPTG, 
Roche Diagnostics Corporation, Indianapolis, USA). After 2 hours of induction, the cells 
were harvested by centrifugation at 8,000 x g for 15 min and frozen at -20 °C until use. 
 
2.3.4 Purification of inclusion bodies for σ70 and the β'-fragment 
A cell pellet (2 g wet weight) was resuspended in 10 ml NTGED-buffer + 10 mM 
EDTA and 100 µg/ml lysozyme. The cells were incubated on ice for 30 min and then 
sonicated at 4°C  (1 cm diameter tip, three times 1 min in 1-s pulses, 80% duty cycle, output 
level position 9, Sonicator W-385 Ultrasonic Inc.). TritonX-100 (1% v/v) was added and 
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vortexed. The recombinant protein in the form of inclusion bodies was separated from the 
soluble lysate by centrifugation at 25,000 x g for 15 min. The inclusion body pellet was 
resuspended by short sonication in 10 ml NTGED-buffer + 1% (v/v) TritonX-100. The 
mixture was centrifuged at 25,000 x g for 15 min and the supernatant discarded. The washed 
inclusion bodies were resuspended in 10 ml NTGED-buffer + 0.1% (v/v) TritonX-100 and 
centrifuged at 25,000 x g for 15 min. The wash was repeated with 10 ml NTGED-buffer + 
0.01% (v/v) TritonX-100 and the suspension of inclusion bodies was aliquoted into 5 equal 
portions (typical yields are between 30 and 40 mg per aliquot) in 2-ml vials prior to 
centrifugation in a Beckman Microfuge®18 centrifuge at maximum speed. Supernatants were 
removed by pipetting and inclusion bodies  were frozen at -20 °C until use. 
 
2.3.5 Ni-NTA purification and IC5-derivatization of the β'-fragment 
One aliquot (typically 35 mg) of β' inclusion bodies were solubilized in 3 ml 
NTTwGu-buffer + 5 mM imidazole and incubated at room temperature for 15 minutes. The 
precipitate was spun down in a microfuge at 18,000 g (14,000 rpm) for 5 min and the 
supernatant was loaded on a BioRad column (10 ml PolyPrep, 0.8x4 cm) with 0.5 ml Ni-
NTA matrix (Qiagen) previously equilibrated with 5 ml NTTwGu-buffer + 5 mM imidazole. 
To remove unbound protein, the column was washed with 5 ml NTTwGu-buffer + 5 mM 
imidazole. To reduce any disulfide bonds the column was washed with 5 ml of freshly 
prepared NTTwGu-buffer + 20 mM imidazole and 2 mM TCEP. TCEP is an odorless white 
powder that can be added as a solid just before use. It dissolves readily in aqueous solutions 
and is very stable unless chelators like EDTA are present (21). Excess TCEP and non-
specifically bound protein were removed by washing with 3 ml NTTwGu-buffer + 20 mM 
imidazole which was saturated with N2 to minimize exposure to O2. The bound protein was 
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derivatized with IC5-maleimide by loading 2 ml freshly prepared NTTwGu-buffer + 20 mM 
imidazole and 0.1 mM IC5-PE-maleimide. IC5-PE-maleimide was dissolved in chloroform 
and divided into aliquots of 0.1 µmol which were then dried down in a Speed-Vac (SpeedVac 
SVC100H, Savant Instruments, Farmingdale, NY). The speedvac was equipped with a glass 
cover unaffected by organic solvents for removal of solvents from samples held in the 
microcentrifuge tubes. A refrigerated condensation trap is placed between the Speed-Vac and 
the vacuum pump, Edwards E2M-12 high vacuum pump, to trap solvents coming off the 
samples. The use of water is not recommended as it causes hydrolysis of the maleimide 
moiety. The flow-through was reloaded onto the column twice before excess dye was 
removed by washing with 3 ml NTTwGu-buffer + 20 mM imidazole. Derivatized protein was 
eluted with NTTwGu-buffer + 200 mM imidazole and stored denatured at -20°C at 
concentrations of around 2 mg/ml. The SDS-PAGE gel of the samples taken at different 
stages during the purification procedure can be seen in Figure 2.3 (Coomassie-stain and IC5-
sensitive fluorescence scan). 
The procedure was also done under non-denaturing conditions after refolding the β'-
fragment into a 65-fold excess of TGE-buffer and binding to the Ni-NTA-resin. In another 
variation of the procedure, we refolded the the column-bound β'-fragment by washing with 
NTTw-buffer and continuing the procedure under non-denaturing conditions by omitting 
GuHCl in the buffers. This was done before the labeling reaction and in another experiment 
after labeling. 
 
2.3.6 Purification and derivatization of σ70 
One aliquot of σ70 inclusion bodies (35 mg) was solubilized by resuspending in 5 ml 
TGE-buffer + 6 M GuHCl. To refold proteins the denaturant was diluted 100-fold by 
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dripping into 500 ml of chilled TGE-buffer + 0.01% TritonX-100 slowly stirring on ice. If 
precipitation occurred, the precipitate was removed by centrifugation at 25,000 g (15,000 
rpm, SS-34 rotor) for 15 min at 4°C. The soluble refolded protein was then bound to an anion 
exchange resin by adding 1 g DE52 (Whatman) dry resin as a suspension in 5 ml TGE-buffer 
+ 0.01% TritonX-100 directly into the mixture. After slow stirring for 30 min, the suspension 
was poured into an empty 25 ml Econo-Pack column (BioRad) and washed with 5 ml NTG-
buffer + 0.01% TritonX-100. To reduce any disulfides formed by dimerization of sigma, 5 ml 
NTG-buffer + 2 mM Tris(2-carboxyethyl)phosphine (TCEP) + 0.01% TritonX-100 was 
loaded onto the column, followed by a wash with 5 ml NTG-buffer + 0.01% TritonX-100 to 
remove TCEP, which would otherwise interfere with maleimide labeling. To label σ70, 1 ml 
NTG-buffer + 0.01% TritonX-100 + 1 mM DTPA-AMCA is loaded onto the resin. The flow-
through was reloaded onto the column 2 times to ensure maximum labeling. The Europium-
complex was formed by loading 5 ml NTG-buffer + 0.01% TritonX-100 + 1 mM EuCl3 onto 
the resin containing the derivatized protein. After a wash with 5 ml NTG-buffer + 0.01% 
TritonX-100, the labeled protein was eluted with TGE-buffer + 500 mM NaCl. The eluted 
fractions were analyzed by SDS-PAGE and pooled according to their purity and protein 
content. The pooled fractions of labeled σ70 were brought up to 50% glycerol or dialyzed 
against storage buffer (final protein concentration of about 2 mg/ml) and were stored at -20°C 
until use. 
Labeling can also be done after purification and elution from the ion-exchange 
column (18) by adding the protein to an aliquot of the dye (same buffers and conditions). The 
procedure can be scaled down 10-fold. Excess label and Eu-ions are then removed by using a 
Pharmacia G50 spin-column. 
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2.3.7 Electrophoretic Mobility Shift (EMS) assay to test complex formation of labeled σ70 
with β'-fragment 
The EMS assays were performed in 20 µl buffer containing 5% glycerol, 50 mM Tris-
HCl, pH 8.8, 50 mM NaCl, bromphenol blue 0.005% (w/v). The standard protein 
concentrations were 0.25 µM σ70 (labeled protein) and 0.1 to 2 µM β'-fragment (labeled 
protein) but can be lowered to 20 nM and 10 nM, respectively at the detection limit of the 
Coomassie blue stain. Labeled σ70 was added to NTG-buffer first. In case of competition 
experiments unlabeled denatured β'-fragment was added subsequently. Denatured labeled β'-
fragment was added last. The solutions were mixed well after addition of each component. 
The mixture was incubated for 5 min at room temperature, and then 15 µl were loaded on a 
pre-cast native PAGE-gel (12-well, 12%, Tris/glycine, NOVEX). The electrophoresis was 
run with pre-chilled buffers, gels and apparatus in the cold room (4°C) at constant voltage of 
120 V (5-20 mA, variable) for 2.5 hours. The IC5-emission was scanned on a Storm system 
(Molecular Dynamics) in the red fluorescence mode. The Europium emission was measured 
using an Fotodyne UV light box (λexcit.= 312 nm) with 6 seconds acquisition time. Total 
protein was stained with Coomassie blue stain using the Gel Code staining solution (Pierce) 
according to the procedure of the manufacturer and scanned with a Hewlett Packard flat bed 
scanner (ScanJet 6200C). 
 
2.4 Results 
2.4.1 Specificity of the labeling reaction 
The specificity of maleimide activated dyes towards reaction with cysteine residues at 
the applied conditions is commonly used in biochemistry. In order to ensure that labeling 
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under the chosen conditions occurs only at the desired position we tested mutant proteins that 
contain no cysteine residue under the same conditions and were not able to observe any 
labeling with maleimide containing fluorescent probes. Thus incorporation of such a probe 
into the single cysteine containing proteins was taken as evidence for the specificity of 
incorporation of the label into this position. 
 
2.4.2 Labeling efficiency of the β'-fragment 
We tested the labeled sample for labeling efficiency by measuring the absorbance of 
the labeled sample (according to manufacturer's information, the molar absorptivity at 650 
nm is approximately 90,000 mol-1cm-1). The derived concentration (1.8 mg/ml) compared 
with the protein concentration (2 mg/ml) measured by the Bradford method (Pierce). The 
SDS-gel in   Fig. 2.3 (4-12% NuPAGE, MES buffer; NOVEX) of a purification under 
denaturing conditions shows no interference of the TCEP reduction with the binding of the 
histidine-tagged protein as well as a good purification of the labeled protein from the free 
dye. Labeling efficiencies were greater than 90% in all cases. Judging from the emission of 
the labeled protein and the free dye in the SDS gel (Fig. 2.3), the remaining content of free 
dye was less than 5%. 
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Figure 2.3: SDS-PAGE gel of the β'-purification and derivatization steps. The Coomassie stain of gel (A) 
illustrates the purification of the β'-fragment throughout the procedure (at 6 M GuHCl). Purification 
from minor impurities can be observed as well as very low elution of the β'-fragment at any time except 
for the fractions 1 to 3 eluted with 200 mM imidazole. The IC5-scan (gel B) was performed with a 
Molecular Dynamics Storm system in the red fluorescence mode and thus shows the IC5-labeled proteins. 
It resembles the identical gel in (A) and was scanned before the staining procedure. Note the significant 
decrease of free label in the eluted fractions. 
2.4.3 Refolding prior to or after labeling of the β'-fragment 
Using a 0.8 ml Ni-NTA column volume, we were able to get a total of 9 mg of labeled 
protein in concentrations of typically 2 mg/ml using denaturing conditions throughout. When 
refolding the protein before or after the labeling step, yields go down dramatically (2.0 mg 
 A 
 
 
 
 
 B 
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protein, 22% yield compared to denaturing conditions). Also the labeled protein tended to 
precipitate further, when concentrations exceeded 0.2 mg/ml (concentrations of initially 0.5 
mg/ml dropped more than 40% over 1 month at -20°C, or less than 1 week at 4°C). We found 
it to be best to keep the protein under denaturing conditions (6M GuHCl) and to refold the 
labeled protein directly into the assay when it was carried out (26). Still it was possible to 
refold the protein by 65-fold dilution into TGE-buffer followed by binding in batch mode. 
Yields and labeling efficiencies were similar to those under denaturing conditions, if the 
refolding efficiency was not considered since we saturated the Ni-NTA columns in all cases 
(see lane marked "flow through" on the SDS-gel in Figure 2.3). Furthermore we observed a 
slightly better overall solubility of the β'-fragment residues 100-309 compared to the β'-
fragment residues 240-309 (data not shown). 
 
2.4.4 Electrophoretic Mobility Shift (EMS) assay to test for the complex formation of 
labeled σ70 and β' 
The EMS assays clearly showed that the labeled as well as the unlabeled proteins 
could form a complex that migrates slower in the native gel than σ70 alone (Figure 2.4). The 
different scanning techniques also confirmed the identity of the bands in the EMS assay. 
Furthermore the EMS assay showed that unlabeled β'-fragment can compete for the labeled 
σ70. Thus unlabeled β'-fragment itself represents a positive control for an agent able to 
interfere with the binding of labeled β'-fragment and σ70 in the assay. We could further show 
that it was possible to shift 100% of the labeled σ70 with the complex. This suggests that all 
the labeled σ70 was active for binding under these conditions. The electrophoresis could be 
run up to 12 hours under described conditions (data not shown). Although the bands got more 
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diffuse with increasing electrophoresis time, the band of the complex never disappears 
indicating a low level of dissociation under these conditions. 
Figure 2.4: The result of two EMS assays. (A) shows increasing amounts of labeled β'-fragment (0, 0.1, 
0.25, 0.5, 1, 1.5, 2 µM) that can shift all the labeled σ70 (250 nM) into the upper band representing the 
complex in the Coomassie-stained gel at the top. The middle frame represents the same gel, but was 
acquired with a UV-box and an orange filter on the camera that can only visualize the Eu-emission due to 
the excitation wavelength (312 nm). It confirms that both bands contain Eu-labeled sigma. The bottom 
frame of the same gel, was taken with a Storm imager (Molecular Dynamics) that can only visualize the 
IC5-label. It confirms that only the upper band contains labeled β'-fragment. The free β'-fragment runs 
as a diffuse band barely migrating into the gel (not shown). In (B) a sample of labeled β'-fragment and 
σ70 in a ratio of 1:1 (250 nM) was taken but prior to mixing, an increasing amount of unlabeled β'-
fragment (0, 0.1, 0.25, 0.5, 1, 1.5, 2 µM) was added to the labeled σ70. The unlabeled β'-fragment can 
clearly compete for the labeled σ70 as can be seen by a loss of the band in the bottom gel of (B). 
2.5 Discussion 
Using fluorescence to monitor sigma binding to DNA has been shown to be an 
effective and very sensitive method (18, 27). In order to use the same technique to monitor 
sigma binding to RNAP, we labeled a fragment (residues 100-309) of the β'-subunit of RNAP 
that contained a N-terminal HMK-site and a His6-tag with IC5-maleimide. A well-
characterized σ70(442C) mutant (18) with all natural cysteine residues mutated to serine 
residues and serine 442 mutated to cysteine was derivatized with a DTPA-AMCA-maleimide 
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Eu-complex. It was shown to be as active in in vitro transcription as the wildtype protein. We 
used the labeled protein to test binding of the labeled β'-fragment. We were able to show with 
EMS assays that the labeled proteins can bind to each other in all combinations with and 
without the label. As controls the unlabeled proteins were tested to determine if they could 
compete with their labeled counterpart. In the EMS assays unlabeled β'-fragment was able to 
compete with the labeled β'-fragment for binding to labeled σ70. From these data we 
conclude that the assay can be used to monitor σ70-to-β'-binding and that the presence of the 
fluorophore on each binding partner has no significant effect on its binding properties. In our 
studies we started with inclusion bodies. In the case of σ70, our results favor refolding prior 
to purification and derivatization to achieve maximum yields and labeling efficiencies. 
However the stability of some proteins like the β'-fragment made it more effective to label 
under denatured conditions and keep the labeled protein denatured until use. In general the 
procedure should be useful for most soluble proteins that are stable under these conditions. 
The described procedures represent a rapid and efficient way to reduce and label 
proteins with a single cysteine on either Ni-NTA (for histidine-tagged proteins) or anion 
exchange columns (for proteins with acidic sites). We could show that TCEP can be used in 
combination with Ni-NTA resin for reduction of proteins prior to their derivatization with 
maleimide derivatives of fluorescent probes. The procedure presented offers a quick and 
efficient alternative to other currently used procedures that require dialysis or further 
chromatographic steps to eliminate free fluorescent dye that can otherwise interfere with 
sensitive fluorescent assays like FRET and LRET assays. 
We are actively using the labeled proteins for in vitro assays and have developed a 
high-throughput screen based on LRET (to be published elsewhere). In these assays we could 
show that both proteins are active in binding by measuring the IC5-emission resulting from 
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LRET upon their binding to each other. Furthermore we could show that this signal could be 
eliminated by addition of unlabeled σ70 that can compete with labeled σ70 for labeled β'-
fragment (data not shown). This could be shown accordingly for unlabeled β'-fragment and 
confirms results from the EMS assays described in this paper. The assay is now being used to 
screen libraries of natural and synthetic compounds as well as for studying sigma binding to 
core RNAP.  
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3.1 Summary 
The binding of sigma factors to core RNA polymerase is essential for specific 
initiation of transcription in eubacteria and is thus critical for cell growth. Since the 
responsible protein-binding regions are highly conserved among all eubacteria but differ 
significantly from eukaryotic RNA polymerases, it is a promising target for drug discovery. 
A homogeneous assay for sigma-binding to RNA polymerase (E. coli) based on 
luminescence resonance energy transfer (LRET) was developed using an europium-labeled 
sigma70 and IC5-labeled fragment of the beta-prime subunit of RNA polymerase (amino acid 
residues 100-309). Inhibition of sigma-binding was measured by the loss of LRET through a 
decrease in IC5-emission. The technical advances offered by LRET resulted in a very robust 
assay suitable for a high-throughput screening and was successfully used to screen a crude 
natural product library. We illustrate this method as a powerful tool to investigate any 
essential protein-protein interaction for basic research and drug discovery. 
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3.2 Introduction 
 The need for new antimicrobial drugs has become an obvious scientific 
challenge since inappropriate use and clinical conditions have favored selection for strains 
resistant to an increasing number of antibiotics. In order to accelerate the pace in which we 
compete with nature, high hopes lie in the exploitation of recent advances in genomic and 
proteomic research. Due to increasingly detailed structural and mechanistic information about 
proteins involved in the central processes of the life cycle of a cell like replication, 
transcription and translation, rationally designed assays can be developed to find inhibitors of 
very specific and vulnerable targets within these biochemical machines. With this paper we 
illustrate the development of a LRET-based high-throughput screen for antimicrobial drugs 
based on the identification of a crucial protein-protein interaction in RNA polymerase 
(RNAP). 
Like the ribosome and DNA polymerase, the bacterial transcription machinery 
appears to offer an attractive target for drug discovery and rational drug design. Any inhibitor 
of the core RNAP assembly with a major sigma factor to form the holoenzyme would inhibit 
the initiation of transcription and therefore would prevent growth and eventually survival of a 
cell. Our group and others have previously identified by biochemical methods the regions in 
E. coli RNA polymerase (a coiled-coil region between amino acid residues 260-309 in the β'-
subunit of E. coli) (1, 2) and its major sigma factor σ70 (region 2.2) largely responsible for 
sigma-core interactions (3, 4). These results have now been confirmed by the structures of T. 
aquaticus holoenzyme (5, 6). Each protein has a remarkably conserved (>80%) amino acid 
sequence (7, 8) among all known eubacteria within these regions. These homologies suggest 
a highly conserved structure and function within the holo form of RNAP, which is crucial for 
a correct initiation of transcription. Any inhibitor of this interaction can thus be expected to 
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be a broad-spectrum antibiotic. This is supported by the fact that induction of expression of 
the β'-fragment (residues 260-309) stops cell growth in E. coli. (9). No σ70 homologue has 
been found in archaea and mammalian cells except for sigma factors in mitochondria (10) 
and chloroplasts (11). However, they do not show a significant homology to their bacterial 
counterparts. This fact implies that there is very little chance of a potential new antibiotic 
interfering with eukaryotic RNAP assembly, which could otherwise lead to serious side 
effects, if it were used as a drug. 
In order to screen for inhibitors of RNAP assembly with sigma, a more simple, fast 
and reliable assay than the ones currently available (12) was developed for the formation of 
the σ70-β'-complex of E. coli. We decided to use LRET (Luminescence Resonance Energy 
Transfer), a recent modification of FRET, that can create the desired signal upon protein 
binding (13-15). The more general term luminescence instead of fluorescence (as in FRET) 
indicates that lanthanide emission is technically not considered as fluorescence (i.e., arising 
from a singlet to singlet transition). The details of LRET have been elegantly described in 
recent reviews by Selvin and Heyduk (16, 17) and will be covered only briefly here. A 
quantitative description of the effect is based on the Förster theory that describes the decrease 
of energy transfer as inversely proportional to sixth-power of the distance between the two 
dyes and is applicable for FRET and LRET. The key differences to FRET result from 
prolonged fluorescent lifetimes of the lanthanide-based donor fluorophores like Eu and Tb (> 
microseconds up to several milliseconds) compared to the short lifetime of most organic-
based fluorophores used in FRET like Cy5 or IC5 (picoseconds up to a microsecond), so that 
LRET offers mainly technical advantages over FRET. 
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Heyduk and co-workers have used LRET to measure DNA binding to σ70 in 
holoenzyme using an Eu-chelate as donor and Cy5 as an acceptor (18). They have been able 
to show its applicability within this system. We adapted the principle by exchanging the Cy5-
labeled polynucleotide for an IC5-labeled β'-fragment (residues 100-309 N-terminally fused 
to a heart-muscle kinase (HMK) recognition site and a His6-Tag). For the resulting 
homogenous assay, we labeled σ70 with an Europium-DTPA-AMCA complex as a donor 
and the HMK-His6-β'(100-309)-fragment with the Cy5-analogue IC5-maleimide (Dojindo) 
(purification and labeling procedures described in Bergendahl et al. 2002 (19)). It is possible 
to monitor complex formation between σ70 and β' simply by looking at the long-lived 
emission of the acceptor (IC5) due to LRET as an optically measurable signal of complex 
formation. Measuring time-resolved fluorescence allows one to start signal acquisition after 
the background fluorescence (potentially from a natural product) and the intrinsic acceptor 
fluorescence have decayed so all short-lived background fluorescence can be excluded from 
the measurement. This leads to a highly favorable signal-to-noise ratio and a higher 
sensitivity and confidence. This is especially important when working with natural product 
samples which often produce a high background fluorescence. The principle of the assay and 
the structure of the dyes are described in Figure 3.1. 
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Figure 3.1: Principle of the LRET assay A) The scheme above shows the principle of how the LRET 
signal in the assay is created upon binding of the labeled proteins β'-100-309 and σ70. The fluorescence of 
the IC5-labeled β'-fragment has decayed during the delay of the data acquisition 50 microseconds after 
excitation at 320 nm. Only the Eu-emission of labeled σ70 and the sensitized IC5 emission in the complex 
can be observed after the delay due to the characteristic long Eu-luminescence lifetime of over 1 
millisecond. B) The spectra of the fluorophores that were used to derivatize the proteins are shown: The 
emission spectrum of the Eu-chelate (Eu-DTPA-AMCA-maleimide) is shown in black. The the absorption 
spectrum (blue) and the emission spectrum (red) of IC5-PE-maleimide are superimposed to show the 
spectral overlap between these dyes that facilitates LRET. C) In the diagram the luminescence is plotted 
versus the time. The graphs show the intensity of the luminescence emitted at 615 nm and 665 nm over 
time. Where as the intrinsic IC5-emission has decayed long before the data acquisitions starts, the 
emission from the IC5 sensitized by LRET goes on for over 1 ms. That way only the IC5-emission due to 
LRET is acquired in the data acquisition window, where as the background emission and the intrinsic 
IC5-fluorescence is excluded.  
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The assay can be performed in a multi-well plate and measured by a multi-plate 
reader to accomplish a high-throughput of a large number of samples from any chemical 
library in an automated way. Typical reaction volumes are 10-200 µL where the components 
including the test substances are mixed directly in the multi-well plate before the plate is 
measured in the reading device. The very sensitive nature of such a fluorescence-based assay 
(typically in the low nanomolar range) provides good accuracy and signal-to-noise ratio, 
avoiding false positive hits in the measurement. We have chosen to screen a marine sponge 
library (20) since it has been successfully screened for cytotoxic compounds. Due to its 
complexity it demanded a high performance of the assay and was therefore well suited to 
evaluate its applicability. We show the robust nature of the assay and its suitability for use as 
a high-throughput screen. 
 
3.3 Experimental procedures 
3.3.1 Materials and chemicals 
 Overproduction, labeling and purification of HMK-His6-β'(100-309) and 
sigma70(442C) were described in (19). The origin of the natural product library comprises 
privately collected samples of marine sponges (20) extracted with acetone and ethylacetate. 
The samples (2 to 5 mg dry weight) were dissolved in 1 ml methanol and diluted 1:50 in 
DMSO for the assay. All chemicals used were purchased from Sigma unless otherwise 
indicated in the text. A multi-plate reader (Wallac, VictorV2 1420) was used to perform the 
LRET assay. Buffers: NTG-buffer: 50 mM NaCl, 50 mM Tris, 5% glycerol; pH 7.9; Storage 
buffer: 50 mM Tris-HCl, 10 µM EDTA, 0.5 M NaCl, 10% glycerol, pH 7.5; TNTw-buffer: 6 
M GuHCl, 50 mM Tris-HCl pH 7.9, 500 mM NaCl, 0.1 % (v/v) Tween20, 400 mM 
imidazole. Core RNA polymerase was prepared according to Thompson et al. (21). 
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3.3.2 LRET assay to test for the inhibition of protein-protein interaction between labeled 
σ70 and the β'-subunit 
The assay was performed in NTG-buffer (200 µL total volume) plus 2.5% DMSO 
(when library samples are used) with 40 nM σ70* (labeled protein) and 30 nM β'*-fragment 
(labeled protein). All assays were performed with refolded σ70*. In the standard assay the 
β'*-fragment was added in denatured form directly into the reaction mixture, which by 10-
fold dilution of GuHCl to 0.15 M in the final assay allowed instant refolding. This was done 
to prevent precipitation of the refolded labeled protein upon storage before the assay (19). In 
order to assure that refolding occurs and to confirm the results from the experiments with 
denatured protein being added, some assays were carried out by adding β'*-fragment in its 
refolded state. 
A stock solution (200 nM) of σ70* was prepared prior to the assay by 1:200 dilution 
with NTG of labeled protein (40 µM) stored at -20°C in Storage buffer. A stock solution 
(1.25 µM) of the β'*-fragment was prepared by dilution of labeled denatured protein (75 µM 
in TNTw-buffer containing 6 M GuHCl) to 1 M GuHCl with NTG and NTG + 6 M GuHCl. 
First, 10 µl of that σ70*-stock solution was mixed with NTG buffer (amount adjusted to give 
a final volume of 200 µl), then the potential inhibitor (5 µL in DMSO), salt or solvent was 
added and finally the 5 µl of denatured labeled β'*-stock solution was added. Salts or 
denaturants were dissolved in NTG buffer according to the desired final concentration to 
maintain standard buffer conditions. Mixing (pipetting up and down three times) after 
addition of each component was very important for reproducible results. The mixture was 
incubated for 30 min at RT and measured in a 96-well plate (Costar 3650) with a multi-plate 
reader (Wallac, VictorV2 1420). For this time-resolved fluorescence measurement, the 
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manufacturer's protocol (LANCE high count 615/665) was used (excitation was with 1000 
flashes at 325 nm; measurement was delayed by 100 µs and data acquired for 50 µs at 615 
and 665 nm). 
In fluorimetric measurements it is common to use a second emission wavelength as an 
internal standard. This allows correction for instrument noise, but also to normalize the signal 
for the actual amount of donor in this particular case. This is possible, since donor and 
acceptor emission wavelengths are well separated and can be acquired separately with the 
multi-plate reader. The IC5-emission is corrected for the very small amount of signal from 
the Eu-emission band (by cross talk measurement of a standard) and then divided by the 
intensity of the Eu signal. The normalization can be included into the overall measurement 
protocol and is described by the manufacturer of the multi-plate reader (Wallac). Fortunately 
the nature of this method allows us to differentiate the loss of signal due to inhibition of 
protein-protein binding from simple absorption caused by the inner filter effect of the 
substance. This will help us to identify false positives in the actual high throughput screen. 
 
3.3.3 In vitro transcription 
The conditions and procedure in the in vitro transcription assay were according to 
those published by Landick et al. (22) except for omitting BSA since it could bind potential 
hydrophobic inhibitors (Assay conditions: 100 mM NaCl, 25 mM Tris HCl pH 7.9, 10 mM 
MgCl2, 1 mM DTT, 0.1 mM EDTA, 5% glycerol, 0.15 mM ApU, 20 nM template DNA, 20 
nM core RNAP, inhibitor in final concentration 2% DMSO, 10 nM  σ70, 25 µM ATP and 
CTP, 10 µM GTP, [α-32P]GTP 20 µCi/100 µl, added in the order listed). As template we 
amplified a 694-bp fragment from the plasmid pCL185 by PCR using the primers 5'-GTT 
TTC CCA GTC ACG AC-3' and 5'-CAG TTC CCT ACT CTC TCG CAT G-3'. Omitting 
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UTP in the reaction mixture and initiating with ApU dinucleotide results in a halted complex 
at position +16 and the transcribed RNA oligonucleotide aug gag agg gac acg g. The assay 
tests for the ability of RNA polymerase holoenzyme (core plus sigma factor) to recognize a 
sigma70-dependent promoter (T7A1; located after base pair 280 of the 694 bp PCR 
fragment) and to initiate as well as elongate to yield the 16-mer. Failure of sigma binding to 
core would result in a lack of product. 
 
3.4 Results 
Labeled as well as the unlabeled proteins were shown to be able to form a complex in 
EMS assays using native PAGE gels (19). The different scanning techniques also confirmed 
the identity of the bands in the EMS-assay. Furthermore the EMS assay showed that 
unlabeled β'-fragment can compete for binding to the labeled σ70. Thus unlabeled β'-
fragment itself represents a positive control for an agent able to interfere with the binding of 
labeled β'-fragment and σ70 in the assay. 
 
3.4.1 Validation of LRET assay to test for the inhibition of protein-protein interaction of 
labeled σ70 and β' with unlabeled proteins 
The LRET assay provides a fast and reproducible alternative to the EMS assay (19) to 
monitor the formation of a protein-protein interaction between labeled σ70 and β'-fragment 
as well as its inhibition. All results of the EMS assay were reproducible by the LRET assay 
and as an example we were able to show competition of labeled σ70 binding to the β'-
fragment by increasing amounts of unlabeled σ70 (Figure 3.2). As a very important feature of 
the assay, the signal-to-noise ratio was between 10 and 11. The limit of detection within the 
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assay using the described instrument was 1 nM of labeled σ70. A maximum of 250 nM 
labeled σ70 could be applied to the assay before diffusion controlled LRET occurred. 
Figure 3.2: Competition of unlabeled σ70, a non-binding σ70 mutant (D403R) (2) and BSA with labeled 
σ70 for binding to the β'-fragment. Only the σ70 (wt) competes for binding to the β'-fragment while the 
other proteins show only non-specific binding resulting in a slightly lower LRET counts value. 
 
3.4.2 Influence of salt and organic solvents on the LRET assay 
In further experiments the dependence of salt (NaCl and GuHCl) and solvents 
(methanol, ethanol and DMSO) were characterized (Figure 3.3). As can be seen, the salt 
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Figure 3.3: Dependence of salt concentration and effect of solvent concentration on the LRET-assay. A: 
With increasing amounts of salt (NaCl, GuHCl), the LRET-signal significantly decreases which should be 
due to the decreased amount of σ70/β'-complex formed. B: Increasing amounts of DMSO, methanol and 
ethanol (0-5%) mixed with the assay buffer prior to the addition of proteins. 
 
major effect on the assay, since the signal drops to 50% when the NaCl concentration is 
increased from 100 to 400 mM. It is known that this β'-fragment interaction with σ70 is 
weakened by increased NaCl concentration. On the other hand DMSO as a common solvent 
for natural products to be tested has no significant effect on the assay. The signal in the 
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LRET-assay was not critically affected by the amount of DMSO present up to 2.5%. In the 
same experiment ethanol and methanol showed a more significant effect over the range of 1 
to 5%. 
 
3.4.3 Performance of the LRET assay in a preliminary screen of 100 sponge extracts 
The concentration of inhibitor in the extracts of marine sponges was estimated to be 
less than 1 µM (assuming a 2 mg sample was 100% a single component of an approximate 
molecular weight of 1000 dissolved in 1 ml methanol, diluted 1:50 in DMSO and 5 µl applied 
to the reaction mixture (200 µl) in the screening assay). Out of 100 samples tested, the 
sample D7 turned out to be the only extract to reduce the signal by roughly 90% in the assay. 
Samples E1, E12, G1, H4 and H6 showed a loss of signal of more than 50% which served as 
an arbitrary threshold (between 55 and 75%). Most samples (like A7 and B12) were 
significantly less active in inhibition of binding judged by the loss of the LRET signal (Figure 
3.4). The variance of the obtained values for the majority of samples spread over a wide 
range of up to 40% loss of signal. 
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Figure 3.4: Screen of 100 extracts from marine sponges with the LRET assay. Inhibition of σ70-binding 
to the β'-fragment was tested with 100 extracts from marine sponges (G. Marriott and J. Tanaka). 
Binding of σ70 to the β'-fragment could be significantly inhibited by fraction D7, while other fractions 
show lower inhibition under these conditions. Assuming a molecular weight of 1000 Da and 100% active 
content in a 2 mg sample, concentrations used are in the low µM range. 
 
3.4.4 Confirmation of hits by the LRET assay and by in vitro transcription 
The concentration of inhibitor in the extracts of marine sponges was examined over 
the range of 30 nM to 2 µM in the LRET assay. Samples A7, B12, E1, E12, G1, H4 and H6 
showed no or very minor inhibition. The sample D7 turned out to be the only extract to give a 
clear inhibition curve over the examined range (Figure 3.5A). That was confirmed by in vitro 
transcription assays. As judged by densitometry of the electrophorograms of the gels, D7 has 
an IC50 value of around 1 µM (Figure 3.5B) assuming the mass and content of the sample 
mentioned above. There was no significant difference between the IC50 values determined by 
LRET and those derived from the in vitro transcription assays. 
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Figure 3.5: Validation of the hits with LRET and in vitro transcription assays. A: Some candidates (D7, 
H4, E1, and G1) resulting from the screen were tested in the LRET assay over a range of 33 nM to 2 µM. 
B: To determine functional effect of an inhibitor of the σ70-β' binding, we tested the candidates in an in 
vitro transcription assay. The estimated concentrations in the assay are between 0.1 µM and 50 µM (E1 
and G1 were similar to H4 and are not shown). The autoradiogram of the sequencing gel was used to 
quantify the transcription product from a halted complex using a "T-less cassette" as a template and 
omitting UTP in the reaction mixture (see methods). The resulting 16-mer can be separated on the gel and 
quantified using Molecular Dynamics software. 
 56
3.5 Discussion 
The use of luminescence resonance energy transfer to investigate protein-protein 
interactions in a homogenous assay has been described before along with its advantages and 
challenges. In spite of that there are not many publications that describe the development of 
an assay based on this technique and actually documenting its final application. In this work 
we describe a straight-forward approach to design a robust high-throughput assay which can 
be exploited for any other pair of proteins that appears to be a valid target for drug discovery. 
There are several reasons to believe that the primary protein-protein interaction 
between bacterial core RNAP and sigma factors represents a prime target for drug discovery. 
The key to the potential of this target is the absolute requirement of sigma binding to core 
RNAP for the initiation of transcription; no bacterial cell can grow upon uptake of an 
inhibitor that effectively blocks this interaction. In addition to a very high bioactivity, a good 
specificity can also be expected since the binding region of both proteins is highly conserved 
among bacteria and is significantly different from any known eukaryotic analogue. This 
implies a very low probability for side effects to occur due to interference with human 
RNAP. The site itself offers another advantage over many potential and specific targets. 
Since the binding site on the β'-subunit of RNAP is suspected to interact with many if not all 
sigma factors of a bacterium, the development of resistance via point mutations against an 
inhibitor which binds to the β'-subunit of RNAP in the binding site is unlikely, since it may 
impair binding to any of the essential sigma factors. Due to the increasing incidence of 
antibiotic resistance and the growing need for new antibiotics, this has recently become a 
major issue in drug discovery. 
Using luminescence resonance energy transfer (LRET) to measure sigma binding to 
core RNAP has been shown by Heyduk and coworkers to be an effective and very sensitive 
method. We used a well-characterized σ70(442C) mutant (18) with all natural cysteine 
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residues mutated to serine residues. Previous work also showed its preserved activity in in 
vitro transcription assays (18). Is derivatized with a DTPA-AMCA-maleimide Eu-complex 
that serves as a donor in the LRET assay. A fragment (residues 100-309) of the β'-subunit of 
RNAP with a N-terminal HMK-recognition site and His6-tag fusion was derivatized with 
IC5-maleimide as LRET acceptor (19). We were able to show with electrophoretic mobility 
shift (EMS) assays (19) and with spectrometric measurements using time-resolved 
fluorescence that the labeled proteins can bind to each other in all combinations with and 
without the label. As controls, the unlabeled proteins were tested to determine if they could 
compete with their labeled counterpart. In both assays, EMS and LRET, unlabeled β'-
fragment was able to compete with labeled β'-fragment for binding to labeled σ70. With this 
data we conclude that the assay can be used to monitor σ70 to β'-binding, and can be used to 
screen for inhibitors of this protein-protein interaction. The assay represents a fast and 
sensitive probe for this particular complex-formation. Substrates and material are either 
readily available or can be prepared in a simple and efficient procedures. All the labeled 
protein components show excellent stability during storage, a great advantage when screening 
large libraries with 10,000 to 100,000 or more substances. Furthermore the LRET assay has a 
very high sensitivity so that measurements can be performed at very low protein 
concentrations of 1 to 100 nM resulting also in a very low cost per screen. 
The suitability of the assay for high-throughput screening of natural and 
combinatorial libraries was demonstrated by a screen of 100 extracts of marine sponges. The 
high demand on the performance of an assay when screening natural product libraries such as 
this, containing of very complex mixtures possibly more than 30 compounds becomes 
obvious by looking at the variance of the obtained values in the LRET assay. This variance 
occurs mainly due to flourophores in the mixtures that can absorb at any of the crucial 
wavelengths of the assay and is generally referred to as "inner-filter effect". The LRET-assay 
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turned out to be very sensitive and reliable. A very good signal-to-noise ratio of above 10 and 
the internal standard method help to distinguish between inhibition and fluorescence 
quenching by an inner filter effect of the test substance. This contributed enormously to 
avoiding false positive readings. Also the very good compatibility of the assay with the use of 
DMSO as a solvent to add test substances adds to its applicability as a high throughput 
screen. Since many natural products and most peptides or small molecules from 
combinatorial libraries have low solubility in water, it is necessary to use organic solvents. In 
this respect DMSO represents the most versatile and potent solvent and since it is often used 
in libraries, its compatibility is crucial for an assay. One sample could be identified by the 
LRET assay as an inhibitor containing extract and was confirmed by an in vitro functional 
assay. The assumptions made to estimate the concentration of the inhibitors should clearly 
overestimate the amount of active compound present so that it is fair to expect an inhibitory 
concentration of 10-100 nM or less. Initial studies on the ability of the D7 extract to inhibit 
cell growth of E. coli cells on culture plates were inconclusive due to limited amounts of 
available material (data not shown). Considering the complexity of the samples, we plan to 
carry out an automated screen of over 1500 more sponge extracts before deciding on which 
samples to characterize in detail. 
In the case of natural product libraries, a positive hit could represent a new class of 
antibiotic, since no substance is known with such a mode of action. On the other hand the 
screen will help to identify known antibiotics, for which the mode of activity has not yet been 
identified or that reveal more than one activity. Together with positive hits from 
combinatorial libraries, these substances can then serve as lead structures to design and tailor 
a new compound with desirable characteristics such as: high activity, specificity, stability, 
ability to enter the cell and low side effects, costs, chance and likelihood of resistance 
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development on the other hand. In addition this assay can serve as a powerful tool to 
investigate the relative binding of different sigma factors and sigma factor mutants to core. 
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Chapter 4 
 
Determination of Equilibrium Binding Constants for Sigma-Binding to 
Core RNA Polymerase by LRET 
 
 
 
 
 
 
 
 
 
 
My contributions are that I developed labeling procedures, assay and data evaluation. 
The experiments were performed in collaboration with Larry C. Anthony from this lab who 
also provided purified σ32. 
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4.1 Summary 
The work in this  summarizes the evaluation of an LRET-assay for its capacity to 
measure equilibrium binding constants. The KDiss for σ70 and σ32 binding to core RNA 
polymerase from E. coli were determined using the proteins randomly labeled with the 
amine-reactive dyes IC3-OSu as LRET acceptor or the terbium chelate Tb-cs124-DTPA-NCS 
as LRET-donor. For σ70 binding to core RNA polymerase a KDiss of 0.5 +/- 0.2 nM was 
obtained  and a KDiss of 28 +/- 10 nM for σ32 by the use of this assay. These values are in 
good correlation with previously described results and therefore confirm the value of this 
LRET-based assay to determine binding constants. 
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4.2 Introduction 
The determination of equilibrium binding constants for the interaction of sigma 
factors with core RNA polymerase has been a challenge since the discovery of the first sigma 
factor from E. coli in 1969 by Burgess et al. (1). Detailed information about the strength of 
the interaction under physiological relevant conditions would be needed to elucidate possible 
competition between the seven different sigma factors for core RNA polymerase in E. coli. 
This knowledge combined with reliable measurements of protein levels and would be an 
important step towards understanding the global transcriptional regulation of gene expression 
controlled by sigma factors. 
Several attempts have been made in the past and a few binding constant 
determinations are published. The results of these publications are summarized for σ70 and 
σ32 in Table 1, which we decided to focus on in this work. Some of the results shown in 
Table 1 were obtained through non-homogeneous assays so that they suffer from a potential 
error since they do not represent equilibrium conditions as described in the introductions. 
This applies for studies using surface plasmon resonance (SPR) (2), size exclusion 
chromatography (SEC) (3), high performance liquid chromatography (HPLC) (4), 
ultracentrifugation (UC) (5) and glycerol gradient ultracentrifugation (GGUC) (6). Values for 
KDiss obtained from in vitro transcription (ivTr) (6) and fluorescence quenching experiments 
(FQ) (4, 7) should be considered homogeneous and could enable measurements at 
equilibrium conditions. 
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Table 1: Previously published binding constants for binding of σ70 and σ32 to core RNA polymerase from 
E. coli. (ND: not determined) 
Method 
 
 
 
Factor 
SPR (2) 
 
 
KDiss in nM 
UC (5) 
 
 
KDiss in nM 
 
HPLC (4)
 
KDiss in nM 
FQ (7) 
 
 
KDiss in nM 
GGUZ 
/ ivTr (6) 
 
KDiss in nM 
SEC (3) 
 
 
KDiss in nM 
σ70 (σD) 190 ND ≤ 10 1 to 0.3 ND 0.26 
σ32 (σH) 
 
 
Assay- 
Conditions 
ND < 2000 ND ND 33 (GGUZ) 
1 (ivTr) 
1.24 
pH 7.4 8.0 6.5 7.5 7.9 7.6 
Temp., °C 20 20 20 22 4 20 
NaCl, mM 150 200 250 (KCl) 200 (KCl) 100 200 
Glycerol, % 
(v/v) 
0 10 0 0 15-35 5 
max. conc. 
of holo 
490 nM 2.5 µM 1 µM 40 nM 100 nM 400 nM 
 
 
The purpose of the investigations presented in this  is to show if the LRET-binding 
assay, presented in Chapter 3 of this thesis, is applicable to the determination of equilibrium 
binding constants (KDiss) for the sigma-to-core interaction. The studies described in Chapter 3 
showed that the sensitivity as well as the detection limits would be suitable for measuring 
binding near nM concentrations. This would be desirable since working at concentrations 
near the binding constant will allow most accurate evaluation of the data and the obtained 
values for KDiss of σ70-binging to core were mostly in the nM range. Several changes to the 
LRET-assay described in Chapter 3 have been made. Instead of the β '-fragment (100-309) 
we now used core RNA polymerase. Controlled labeling of core with a single fluorophore 
was investigated using intein-mediated expressed protein ligation (8) with the use of an IC5-
labeled cysteine (synthesized following the synthesis strategy similar to the one described in 
Mukhopadhyay et al. (9)). Since this approach resulted in very low yields of fluorescence 
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labeled protein unsuitable for this investigations, a different approach was chosen. We 
decided to randomly label sigma factors and core RNA polymerase from E. coli using amine-
reactive fluorescent probes. The RNA polymerase subunits contain the following number of 
lysine residues: α 16, β 80, β' 87, σ70 34 and σ32 16. Not all of them will be accessible for 
derivatization, but a large number of sites are expected to be available for fluorescence 
labeling. Succimidyl ester (OSu) and isothiocyanates (NCS) were used for selective labeling 
of the primary amines in lysine residues (10). The reaction scheme for these derivatizations is 
shown in Figure 4.1. 
 
 
Figure 4.1: Labeling reactions used for fluorescence labeling of σ70 and core RNA polymerase 
  
For availability reasons we switched from the europium chelate to the terbium chelate 
carbocystryl24-diethyletriamine-pentaacetate-phenylalanine isothiocyanate terbium(III) 
 A) Reaction of a primary amine with an isothiocyanate:
B) Reaction of a primary amine with a succinimidylester:
N H3NSC NH
N
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S
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 68
(cs124-DTPA-Phe-NCS•Tb3+) and its compatible acceptor IC3-OSu. The structures of these 
dyes and a diagram explaining the principle of LRET with these dyes is shown in Figure 4.2. 
 
Figure 4.2: Principle of LRET with Tb-donor and IC3-acceptor. The Tb3+-ion is excited by an inter 
system crossing from the antenna molecule (carbostyril cs124) that can be excited by UV light at 325 nm. 
The terbium can now fluoresce with its particular emission spectrum, which contains a maximum at 490 
nm applicable for observation in this setup. If the acceptor fluorophore IC3 is in close proximity (< 10 
nm) it can act as a donor transferring its energy by LRET. That sensitizes IC3 which now fluoresces with 
a lifetime enormously increased from 1 ns to about 2 ms corresponding to the Tb-ion. 
 
Emission and absorption spectra of IC3 and the Tb-chelate are shown in Figure 4.3. 
The maximum emission of the Tb-ion overlaps perfectly with the absorption spectrum of the 
IC3. That makes it a very good LRET-pair, enabling maximum energy transfer, which at the 
same time leads to an optimal signal. 
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Figure 4.3: Emission and absorption spectra of Tb and IC3 from the used dyes. The good overlap of the 
Tb-emission spectrum (green) and the IC3-absorption spectrum (left, black) leads to very good LRET. 
Also the maximum of the IC3-emission (indicated by the dotted red line) allows for good detection, since 
it contains minimal contribution by the Tb-emission (crosstalk). 
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In order to fit the data from the LRET-assay for determination of KDiss we performed 
the following calculations based on the definition of the binding constant. Assuming a 
bimolecular binding reaction (all considered as correspondingly labeled): 
(1) σ + core      holo 
therefore KDiss is defined by: 
(2) [ ] [ ][ ]holo
coreσKDiss =  
with 
(3)  [σ]  = concentration of free σ (at equilibrium) 
(4)  [core] = concentration of free core (at equilibrium) 
(5)  [holo] = concentration of free holo (at equilibrium) 
(6)  [σ]0  = starting concentration of σ  
(7)  [core]0 = starting concentration of core 
follows: 
(8) KDiss·[holo] = ([σ]0 - [holo]) · ([core]0 - [holo]) 
Since the LRET assay is an indirect measure of [holo] and [σ]0 is kept constant while varying 
[core]0 in every separate experiment, equation (8) has to be rearranged to get [holo] in 
dependence of [core]0. 
(9) [holo]2 + (-[σ]0 - KDiss -[core]0) · [holo] + [σ]0 ·  [core]0 = 0 
Solving the quadratic equation (9) results in: 
(10)
 
[ ] [ ]( ) [ ] [ ]( ) [ ] [ ]00
2
00
2
00
42
corecoreKcoreKy DissDiss σσσ −−−−±−−−=  
 
Normalization was done with equation (11). 
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(11) y = (LRET signal) / (maximum LRET signal) · 100 
 
Equation (10) was used to fit the data from the LRET assay using Origin 7.0 (Microcal 
Software Inc., Northampton, MA). 
 
4.3 Experimental procedures 
4.3.1 Materials and chemicals 
 A multi-plate reader (Wallac, VictorV2 1420) was used to perform the LRET 
assays. The assays were done in Costar 3915 8x12 multiwell plates. IC3-OSu was purchased 
from Dojindo Molecular Technologies, Inc. (Gaithersburg, USA). cs124-DTPA-Phe-
NCS•Tb3+ was a generous gift from PanVera (Madison, WI). All other chemicals were 
purchased from Sigma unless otherwise indicated in the text. Purified RNA polymerase was 
made as described in Thompson et al. (11). Purified sigma factors were made as described in 
Anthony et al. (12). 
 
4.3.2 Buffers 
10x PBS buffer: 1.55 M NaCl, 10.6 mM KH2PO4, 29.6 mM Na2HPO4·7 H2O, pH 7.4; 
carbonate buffer: 1.7 g Na2CO3, 2.8 g NaHCO3 in 100 ml H2O at pH 8.5; Blotto: 1% (v/v) 
non-fat dry milk powder in PBS-buffer. loading buffer: 50 mM NaCl, 50 mM Tris HCl pH 
7.9, 5% glycerol. NTG buffer: 300 mM NaCl, 50 mM Tris HCl pH 7.9, 5% glycerol. 
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4.3.3 Fluorescence labeling of σ70,  σ32 and core RNA polymerase 
The proteins were dialyzed into carbonate buffer. The protein concentration was 
adjusted by dilution with carbonate buffer to 0.5 mg/ml. In the case of core RNA polymerase, 
1 mg of IC3-OSu was dissolved in 1 ml of chloroform and divided into 10 aliquots of 100 µl 
each in 1.5 ml Eppendorf vials. The chloroform is evaporated in a Speed Vac (5-10 minutes) 
and the vials are stored in sealed, light-excluding bag at -20°C. These aliquots were further 
divided to give 10 µg per aliquot. One aliquot of 10 µg IC3-OSu were dissolved in 10 µl 
DMSO (1.3 nmol/µl) and 2 µl were added to 1 ml of core RNA polymerase (0.5 mg/ml; 1.3 
nmol) to give a 2-fold ratio of IC3-OSu to protein. While the reaction was incubated for 30 
minutes at room temperature (24°C), a gravity flow column was prepared with 1 ml DEAE 
cellulose (DE-52, Whatman) and equilibrated with the loading buffer. The labeling reaction 
was diluted 10-fold with loading buffer and then loaded onto the resin. After washing with 10 
ml loading buffer, the labeled protein was eluted with NTG-buffer. This was done to separate 
the labeled proteins from the unbound label which could interfere with the LRET assay. The 
same procedure was performed with σ70 and  σ32 using cs124-DTPA-Phe-NCS•Tb3+ (MW: 
909 g/mol) with the same concentrations for labeling. Ion exchange chromatography was 
used in place of dialysis, since we observed very poor dialysis efficiency for the cyanine dyes 
and the Tb-chelate. 
 
4.3.4 LRET assay 
The LRET-binding assays were performed in NTG buffer at (20°C). The 
concentration of sigma factor was kept constant at 10 nM. Core concentrations were varied to 
0, 0.5, 1, 5, 10, 20, 25, 40, 50, 60, 75, and 100 nM. After 5 minutes incubation at 20°C the 
samples were measured. As protocol for the plate reader we used a LANCE template 
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provided by the manufacturer. The excitation was done with 1000 flashes at 325 nm and the 
emissions at 490 nm (Tb-specific) and 570 nm (IC5-specific) with a 50 µs time delay after 
excitation and a counting period of 50 µs. The LANCE correction offered by the 
manufacturer's software was used to correct for background and crosstalk. 
4.4 Results 
 The results of the assay are presented graphically in Figure 4 and 5. 
 
Figure 4.4: Fit of the binding assay data with σ70 at 300 mM NaCl. The box in the corner to the right 
summarizes the fitting data including chi-values, the binding constant KDiss and the fitted maximal value 
at saturated holo. 
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Figure 4.5: Fit of the binding assay data with σ32 at 300 mM NaCl. The box in the upper right corner 
summarizes the fitting data including chi2-values, the binding constant KDiss and the fitted maximal value 
at saturated holo. 
 
According to the data, σ70 binds core with a binding constant KDiss of 0.5 nM (+/- 0.2 
nM) and σ32 binds core with a binding constant KDiss of 28 nM (+/- 10 nM) at 20°C, 50 mM 
Tris HCl pH 7.9, 300 mM NaCl and 5% glycerol. 
 
4.5 Discussion 
Many different techniques have been used to determine the equilibrium binding 
constants for sigma-binding to core RNA polymerase. The evaluation and especially the 
comparison of the results has to be treated with great caution, since many parameters like salt 
concentration, temperature and pH influence the binding constant. Additionally some non-
homogeneous techniques are limited to the fact that they disturb the binding equilibrium by 
separating the free components from their complex or through adsorption phenomena. The 
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conditions in this investigations were based on the experience gained by the previously 
published work. We have chosen to work at 300 nM salt (NaCl) to avoid aggregation of core 
and holo forms of RNA polymerase that was described by Gill et al. (4). Other parameters 
like pH (7.9) and temperature (20°C) were commonly used in the described studies. 
The values for KDiss obtained in this study was 0.5 +/- 0.2 nM for σ70 and 28 +/- 10 
nM for σ32. Although the confidence levels of the fitting procedure indicated by the chi-
square values were not satisfactory, these numbers are well within the range of previously 
reported results. Especially those values that were obtained with homogenous techniques for 
σ70 by Gill et al.(4) and Wu et al. (7) and for σ32 by Joo et al. (6), should be taken to compare 
these new results (see Table 1). Judged by the results from the LRET assay and their 
similarity to previous published numbers this technique is well suited to study binding 
constants of nanomolar magnitude. It will be difficult to use the assay for weaker interactions, 
since limitations in the workable range does currently not allow to use higher than 200-300 
nM concentrations of dye due to interference by diffusion-controlled LRET. Hence it will be 
impossible with the current method to reach saturation if proteins with binding constants of 
larger than 20 nM are investigated. Unfortunately just that region is very important for a good 
fitting evaluation and hence important for the reliability of the data obtained. 
In order to use this LRET assay for the determination of new values for sigma-to-core 
binding constants with enhanced reliability, a few but very important improvements of the 
assay have to be pursued. It will be necessary to achieve better chi-square values, possibly 
through a greater number of measurements. If that is impossible, the fitting procedure has to 
be evaluated and possibly a different equation has to be used that describes the binding 
process more accurately. Gill et al. (4) and others agree that the assumption of a perfect 
bimolecular binding process is already a compromise, since it is known that there are 
multiple allosteric rearrangements upon binding of sigma to core that will certainly have an 
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effect on the way in which the process has to be described quantitatively. A few technical 
improvements could be considered. To avoid adsorption to the plate walls low affinity "Non-
binding Surface" black opaque microplates should be chosen, that are especially treated with 
a proprietary polyethylene oxide-like material especially recommended for such fluorescence 
assays. Gill et al. (4) have also stated that heterogeneously fluorescence labeled proteins 
increase the uncertainty of such assays, so that it might be necessary to improve single 
labeling techniques and investigate the use of single labeled proteins. An extensive study of 
all seven sigma factors from E. coli under several conditions will be necessary to extend this 
study in order to obtain values with sufficient confidence levels and to gain new knowledge 
about sigma binding to core RNA polymerase. The ease of the procedure makes it a highly 
desirable tool for these measurements. 
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Chapter 5 
 
A Cross-Reactive Polyol-Responsive Monoclonal Antibody Useful for 
Isolation of Core RNA Polymerase from Many Bacterial Species 
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5.1 Summary 
The use of antibodies for protein purification is a powerful technique but the release 
of the target protein in its active form is often difficult. So called “polyol-responsive” 
monoclonal antibodies (PR-MAbs) have a feature that allows elution of the antigen under 
very gentle conditions, so that even multi-subunit proteins can be released in their active 
form. In this work a PR-MAb, 8RB13, was isolated that can purify RNA polymerase (RNAP) 
from many different bacterial species. High specificity towards RNAP with a broad species 
cross-reactivity was achieved by immunization with RNAP from Escherichia coli and 
screening with Bacillus subtilis RNA polymerase. The isolated MAb could detect the beta 
subunit of RNA polymerase from 11 out of 13 species tested on a Western blot. Four of these 
species E. coli, B. subtilis, Pseudomonas aeruginosa and Streptomyces coelicolor were 
subjected to immunoaffinity purification yielding RNA polymerases that were active in in 
vitro transcription and seemed to be primarily core polymerase, lacking sigma subunits. 
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5.2 Introduction 
 The purification of proteins using antibodies has been an important tool in 
protein purification. Monoclonal antibodies (MAbs) can be selected for high specificity and 
very strong binding to their antigen. This allows immunoaffinity binding and purification of a 
target protein from a very complex mixture like whole cell extracts even if it is present only 
in very low concentrations. A major disadvantage can be the fact that very harsh conditions 
like denaturants, detergents or extreme pH are usually required to release the desired protein 
from the antibody. Our lab has developed a method for protein purification using a 
remarkable property of certain MAbs that are called “polyol-responsive” (1-5). In the case of 
polyol-responsive MAbs (PR-MAbs), the antigen can be eluted by applying polyol-
containing buffers (ethylene glycol, 1,2-propanediol or 2,4-butanediol) and salt, so gentle that 
even large protein complexes like holo RNA polymerase from E. coli (6 subunits, about 450 
kDa) or RNA polymerase II from Saccharomyces cerevisiae (12 subunits, about 515 kDa) are 
preserved (6). 
PR-MAbs were made by standard hybridoma methods. MAbs can be easily screened 
for polyol-responsiveness and cross-reactivity by a modified enzyme-linked 
immunoabsorbent assay (ELISA) that has been described as an ELISA-elution assay (2). We 
find that 5-10% of the MAbs produced in a fusion of mouse spleen and plasmacytoma cells 
turn out to be polyol-responsive, depending on the fusion and antigen. An immunoaffinity 
column to purify RNA polymerase from cell extracts can be made by covalently attaching 
purified MAbs from ascites fluid or hybridoma culture to a cyanogen bromide (CNBr)-
activated resin. The cell extracts are pretreated with polyethyleneimine (PEI) and ammonium 
sulfate precipitation. Resolubilized ammonium sulfate precipitates are loaded onto the 
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immunoaffinity column and can be eluted under very gentle conditions using high salt and a 
polyol like 1,2-propanediol. 
Here we describe the isolation and use of a polyol-responsive antibody that reacts 
with RNA polymerase from different bacteria. MAb-producing hybridoma cells were made 
from an E. coli RNA polymerase-immunized mouse. The MAb-containing culture 
supernatants from hybridoma cells were screened for recognition of B. subtilis RNA 
polymerase by ELISA and thus for their cross-reactivity between RNA polymerases from E. 
coli and B. subtilis. Two MAbs were tested for cross reactivity with RNA polymerase from 
12 bacterial species in Western blots. The PR-MAb 8RB13 was subjected to immunoaffinity 
purification of RNA polymerases from E. coli, B. subtilis, Pseudomonas aeruginosa and 
Streptomyces coelicolor. 
 
5.3 Experimental procedures 
5.3.1 Materials and chemicals 
 Media ingredients were bought from DIFCO. CNBr-activated Sepharose was 
purchased from Sigma. Disposable columns were purchased from Bio-Rad. DEAE-cellulose 
discs were purchased from McLeester Research Equipment, Inc. (Madison, WI). [α-32P]UTP 
was purchased from NEN. Calf thymus DNA was purchased from Roche. All chemicals used 
were purchased from Sigma unless otherwise indicated in the text. Core RNA polymerase for 
immunization of mice was prepared from E. coli according to Thompson et al. (3). 
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5.3.2 Strains 
Escherichia coli K12 (MG1655, gift from Frederick R. Blattner, UW Madison), 
Bacillus subtilis ATCC 6051, Streptomyces coelicolor A3(2) (gift from Prof. Sir David 
Hopwood, John Innes Centre, Norwich, UK), Shigella boydii ATCC 9207, Pseudomonas 
aeruginosa ATCC 10145, Pseudomonas fluorescens ATCC 13525, Pseudomonas putida 
ATCC 12633, Agrobacterium tumefaeciens ATCC 15955, Klebsiella pneumoniae ATCC 
13883. 
 
5.3.3 SDS PAGE samples 
Rhodobacter sphaeroides (whole cell extract, gift from Tim Donohue, UW Madison), 
Anabena sp. 7120 (purified RNA polymerase, gift from Robert Hazelkorn, University of 
Chicago), Streptococcus pneumoniae (whole cell extract, gift from Elizabeth Campbell, 
Rockefeller University, New York), Bacillus subtilis (purified RNA polymerase, gift from 
Glenn Chambliss, UW Madison). 
 
5.3.4 Media 
LB medium (Lennox): 10 g Bacto Tryptone, 5 g Bacto Yeast Extract, 5 g NaCl in 1 l 
H20; Brain Heart Infusion (BHI) medium: 37 g BHI in 1 l H20; Yeast Extract-Malt Extract 
(YEME) Medium: 5 g Bacto Peptone, 3 g Bacto Yeast Extract, 3 g Oxoid Malt Extract, 10 g 
glucose, 340 g sucrose in 1 l H20, 2 ml of 2.5 M MgCl2·6H2O added after autoclaving. 
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5.3.5 Buffers 
Lysis buffer: 200 mM NaCl, 50 mM Tris-HCl pH 7.9, 0.1 mM EDTA; 0.1 mM DTT, 
5% glycerol, TE buffer: 50 mM Tris-HCl pH 7.9, 0.1 mM EDTA; PR-equilibration buffer: 50 
mM Tris-HCl pH 7.9, 0.1 mM EDTA, 150 mM NaCl; PR-wash buffer: 50 mM Tris-HCl pH 
7.9, 0.1 mM EDTA, 500 mM NaCl; PR-elution buffer: 50 mM Tris-HCl pH 7.9, 0.1 mM 
EDTA, 700 mM ammonium sulfate, 40% 1,2-propanediol; storage buffer: 200 mM NaCl, 50 
mM Tris-HCl pH 7.9, 0.1 mM EDTA; 0.1 mM DTT, 50% glycerol. 
 
5.3.6 Cell growth and cell extract preparation 
All cells subjected to Western blot assays or purification were harvested during late 
logarithmic growth phase. B. subtilis ATCC 6051 was grown in BHI medium at 37°C, S. 
coelicolor A3(2) was grown in YEME medium at 30°C for 2 days. All other cells were 
grown in LB medium at 37°C. Cells were isolated by centrifugation, resuspended in 10 ml 
lysis buffer, lysed by incubation with 100 µg hen lysozyme per ml on ice for 30 min and 
sonication. SDS PAGE gels of cell extracts were loaded with approximately 1 µg of total 
protein. 
 
5.3.7 Isolation of MAb 8RB13 
The procedure used to make monoclonal antibodies 8RB13 and 8RC8 followed the 
one described in Thompson et al. (3). Briefly a mouse was immunized with 10, 15 and 20 µg 
of purified core from E. coli in 2-week intervals. The spleen was harvested 4 weeks after the 
last immunization and 3 days after boosting the mouse with an injection of 100 µg of core. 
Isolated spleen cells were fused with plasmacytoma cells (cell line NS1). After the hybridoma 
cells were plated in selected medium, they were selected for antibody production by ELISA 
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and Western blots for reactivity towards core RNAP from B. subtilis and E. coli. With the 
ELISA-elution assays we determined the polyol responsiveness. In this ELISA-derived assay, 
we washed the multi-well plates with PR-elution buffer. Under these conditions most PR-
responsive MAbs are washed away from their antigen. The subsequent detection with 
secondary antibody conjugated to peroxidase shows a decreased signal of 50% or less for PR-
responsive MAbs. Selected cells were cloned by dilution and expanded for MAb production 
in culture or ascites production. 
 
5.3.8 Preparation of an 8RB13 immunoaffinity column 
The procedure used to make an immunoaffinity column with 8RB13 followed the one 
described in Thompson et al. (3). Briefly the antibody was purified by 45% saturated 
ammonium sulfate precipitation and passage through a DE52 column at pH 6.9. The minor 
impurities that are still present at this point do not interfere with the final immunoaffinity 
chromatography step. To make an 8RB13 immunoaffinity column, 9 mg of purified antibody 
(judged by absorption using a molar absorptivity of 200,000 M-1 cm-1) was conjugated per 1 g 
of dry CNBr-activated Sepharose to result in a final level of 2.5 mg MAb per ml packed wet 
resin. 
 
5.3.9 Immunoaffinity chromatography with 8RB13 
The procedure used for immunoaffinity chromatography with 8RB13 followed the 
one described in Thompson et al. (3). Briefly nucleic acids and proteins are precipitated by 
adding 10% (v/v) PEI to a final concentration of 0.2% (v/v) PEI at low salt (0.1 M NaCl) to a 
10 ml cell extract of 5 g cells (wet weight). RNA polymerase was eluted from the PEI-pellet 
with 1 M NaCl and precipitated with 35 g ammonium sulfate per 100 ml. The ammonium 
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sulfate pellet was dissolved in TE buffer to give 150 mM salt (judged by conductivity) and 
loaded on a 2 ml 8RB13-immunoaffinity column equilibrated with PR-equlibration buffer. 
After washing with PR-wash buffer, RNA polymerase is eluted with PR-elution buffer that 
contains 40% 1,2-propanediol and 0.7 M ammonium sulfate that releases the antigen from the 
PR-MAb.  
 
5.3.10 Nonspecific in vitro transcription 
The conditions and procedure in the in vitro transcription assay were: 100 µl total 
volume, 100 mM NaCl, 25 mM Tris HCl pH7.9, 10 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, 
5% glycerol, 2 µg calf thymus DNA, 50 nM core RNA polymerase, 200 µM ATP, GTP and 
CTP, 50 µM UTP, and 0.1 µCi/µl [α-32P]UTP (12 µM). Reactions were incubated at 37°C 
for 10 min, before they were quenched with 25 µl of stop mix (0.1 M EDTA, 5% SDS). 75 µl 
of the quenched reaction was applied to DEAE-cellulose discs and dried under a heat lamp. 
The dried discs were washed three times with 350 mM Na2HPO4 and once each with H2O 
and with 95% ethanol. The dried discs were subjected to scintillation counting using 5 ml of 
BioSafe II mix. The assay tests for the ability of core RNA polymerase to transcribe from 
denatured DNA showed its nonspecific transcriptional activity. 
5.4 Results 
The fusion of spleen cells taken from a mouse immunized with RNA polymerase 
from E. coli with plasmacytoma cells yielded approximately 300 isolated hybridoma cell 
lines. Two cell lines, secreting 8RC8 and 8RB13 (8th fusion to core in the lab, MAb for 
RpoC and RpoB from clone 8 and 13, respectively), were isolated after screening for cross-
reactivity between E. coli and B. subtilis RNA polymerase. The effective ammonium sulfate 
and 1,2-propanediol concentrations were determined by the ELISA-elution assay (Figure 
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5.1). The results from the ELISA-elution assay can differ from the behavior of the 
immobilized antibody in immunoaffinity chromatography. Thus we have chosen to use 
slightly higher salt and polyol concentrations, than suggested by the assay, in order to ensure 
efficient elution of RNA polymerase from an 8RB13 column. 
 
 
Figure 5.1: ELISA-elution assay for 8RB13. In the ELISA-elution assay we tested 8RB13 with 1,2-
propanediol concentrations at 0, 10, 20, 30, 40 and 50% (v/v) at ammonium sulfate concentrations of 0, 
0.25, 0.5 and 0.75 M. Note that the release is a combined effect of salt and 1,2-propanediol. 
 
The isotypes of both MAbs were identified by an ELISA-based test as being IgG1 
(data not shown). 8RC8 recognizes the beta prime subunit (RpoC) and 8RB13 recognizes the 
beta subunit (RpoB) of RNA polymerase as determined by western blots (data not shown). 
They showed broad cross-reactivity to different bacteria as follows: E. coli (8RC8/8RB13), 
B. subtilis (8RC8/8RB13), Shigella boydii (8RC8/8RB13), Rhodobacter sphaeroides (8RC8), 
Pseudomonas aeruginosa (8RC8/8RB13), Pseudomonas fluorescens (8RC8/8RB13), 
Pseudomonas putida (8RC8/8RB13), Agrobacterium tumefaeciens (8RC8/8RB13), Anabena 
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sp. (8RB13), Klebsiella pneumoniae (8RC8/8RB13), Streptococcus pneumoniae (8RC8) 
(Figure 5.2) and S. coelicolor (8RB13, data not shown). 
 
 
Figure 5.2: Western Blots with 8RC8 and 8RB13 reacting with RNA polymerases from different species. 
Blotted RNA polymerases were incubated in the supernatants of the hybridoma clones for 1 hour and 
then subjected to the regular ECL kit procedure (Amersham). The names of species with RNA 
polymerase cross-reactive to the MAbs are indicated by bold letters. 
 
The hybridoma cell lines producing 8RC8 and 8RB13 were injected into and grown in 
the peritoneum of mice in order to obtain ascites fluid that contains a high concentration of 
MAb. These were then purified by ammonium sulfate precipitation followed by anion 
exchange chromatography with a DE-52 resin. The minor impurities that are still present at 
this point do not interfere with the final immunoaffinity chromatography step. The MAbs 
were then immobilized on a cyanogen bromide-activated Sepharose column. This 
immunoaffinity column was used to purify the antigen from cell extracts after removal of 
DNA by PEI precipitation and a 0-45% saturated ammonium sulfate cut. A typical elution 
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from a NT73 immunoaffinity column (NT73 is a polyol-responsive MAb, used for 
purification of E. coli RNA polymerase) is shown in Figure 5.3 last lane.  
 
Figure 5.3: Comparison of an immunoaffinity purification of RNA polymerase from E. coli, S. coelicolor, 
B. subtilis and P. aeruginosa. The left gel shows the different samples taken during the purification of 
RNA polymerase from E. coli with 8RB13 (left). Lanes: 1-whole cells, 2-insoluble pellet, 3-cell extract, 4-
ammonium sulfate pellet, 5-ammonium sulfate supernatant, 6-PEI pellet, 7-load, 8-wash, 9-15-elution 
fractions. To the right, the RNA polymerase from E. coli, S. coelicolor,  B. subtilis and P. aeruginosa 
purified with 8RB13 are shown. The rightmost lane shows the RNA polymerase from E. coli purified with 
PR-MAb NT73. The transcription factors bound to the RNA polymerase complexes are purified as a 
complex by NT73. The 8RB13 column binds only the core enzyme of E. coli. Positions of polymerase 
subunits are indicated. Asterisks indicate unknown proteins. 
 
Only 8RB13 of the two cross-reactive MAbs turned out to be capable of binding RNA 
polymerase in solution, so that it could be used in immunoaffinity chromatography. We 
tested an 8RB13 column with extracts of E. coli, S. coelicolor, B. subtilis and P. aeruginosa 
for RNA polymerase purification. The SDS PAGE gel shown in Figure 5.3 was loaded with 
samples taken during the purification and elution fractions from the E. coli preparation. 
Samples of the purified RNA polymerases from the other organisms are shown to the right. 
We got yields of 0.1 to 0.75 mg of almost pure core RNA polymerase per 1 g of wet cells that 
was surprisingly free of sigma70 as tested by Western blot using 2G10, a MAb cross-reactive 
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for major sigma factors from different species (7) as primary antibody (data not shown). The 
activity of the purified RNA polymerases was tested in an in vitro transcription assay. All 
samples were active for transcription (Table 1). 
Table 1: Summary of core RNA polymerase-purifications from 4 different bacteria using immunoaffinity 
chromatography with the PR-MAb 8RB13, illustrating activity and yield of each preparation. 
Organism 
Relative Non-specific
Transcription 
(% activity of E. coli) 
Yield 
(mg/g wet cells) 
E. coli 100 0.5 
B. subtilis 13 0.4 
P. aeruginosa 43 0.75 
S. coelicolor 8 0.1 
 
Note that the conditions used were optimized for E. coli RNA polymerase 
transcription and are probably not optimal for transcription activity of the other RNA 
polymerases. 
5.5 Discussion 
 Polyol-responsive MAbs have been shown to be a valuable tool to purify RNA 
polymerase from E. coli and eukaryotic RNA polymerase II (4, 8). In this work we isolated 
two new MAbs, 8RB13 and 8RC8, with cross-reactivity to a number of prokaryotic RNA 
polymerases. We could show cross-reactivity of 8RC8 and 8RB13 on a Western-blot for the 
beta prime-subunit and to the beta-subunit of RNA polymerase, respectively, for E. coli 
(8RC8/8RB13), B. subtilis (8RC8/8RB13), S. boydii (8RC8/8RB13), R. sphaeroides (8RC8), 
P. aeruginosa (8RC8/8RB13), P. fluorescens (8RC8/8RB13), P. putida (8RC8/8RB13), A. 
tumefaeciens (8RC8/8RB13), Anabena sp. (8RB13), K. pneumoniae (8RC8/8RB13) and S. 
pneumoniae (8RC8). The cross-reactivity of the antibodies can be explained by the 
assumption that the epitope of each is a highly conserved motif in the recognized subunit of 
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RNA polymerase. Although 8RB8 was polyol-responsive in the ELISA elution assay, it could 
not pull RNA polymerase out of cell extracts and thus could not be used for immunoaffinity 
chromatography. This is likely because the epitope of 8RC8 is not exposed in its native form 
but is exposed in its immobilized form, when it is bound to the polystyrene surface of the 
multi-well plate. 
The MAb 8RB13 was able to purify RNA polymerase from all 4 tested bacteria E. 
coli, B. subtilis, P. aeruginosa and S. coelicolor in a short immunoaffinity chromatography 
procedure. In addition, 8RB13 also gives a very pure core RNA polymerase without the need 
of using a BioRex70 column to remove the bound transcription factors. We tested the RNAP 
preparations by Western blots using an antibody (2G10) (7) highly sensitive and cross-
reactive to the major sigma factor from different bacterial species. We were able to detect 
only a negligible amount of sigma70 or its equivalent in all four preparations. The reason for 
discrimination for the core enzyme by 8RB13 could be either a steric or allosteric effect of 
the MAb on RNA polymerase that either prevents holo RNA polymerase from binding or that 
releases sigma factors from the holoenzyme, respectively. The cross-reactivity of 8RB13 to 
Anabena is remarkable, since it belongs to the family of cyanobacteria and is therefore 
phylogenetically very different. The cross-reactivity nevertheless points to a significant 
similarity that was conserved over a broad range of evolution. However we did not see cross-
reactivity of 8RB13 with yeast, wheat germ and calf thymus RNA polymerase in a Western 
blot (data not shown). 
In future experiments we will determine the epitope recognized by 8BR13 and its 
effect on RNA polymerase activity in in vitro transcription experiments. That way we can 
study the structural as well as mechanistic effects that 8RB13 may have on RNA polymerase. 
8RB13 has been shown to be valuable for purification of mutants and chimeras of RNA 
polymerase that were not amenable to purification with the conventional purification 
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strategies (unpublished results from this lab). Additionally we will evaluate 8RB13 for its 
utility to purify RNA polymerase from other species like Helicobacter pylori, Mycobacterium 
tuberculosis, Staphylococcus aureus and Yersinia pestis that have pharmacological relevance. 
We have developed a screen for inhibitors of the sigma to core RNA polymerase interaction 
for the E. coli machinery (9, Chapter 3). With the purified enzymes we can test the effect of 
these inhibitors on other systems and thus evaluate their cross-reactivity. 
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Chapter 6 
 
A Fast Western Blot Procedure Improved for Quantitative Analysis by 
Direct Fluorescence Labeling of Primary Antibodies 
 
 
 
This Chapter has been submitted for publication as: 
Bergendahl, V., Glaser, B. T., and Burgess, R. R., A Fast Western Blot Procedure Improved 
for Quantitative Analysis by Direct Fluorescence Labeling of Primary Antibodies. J Immunol 
Methods. 
 
My contributions are that I performed all the experiments and wrote the manuscript. Bryan T. 
Glaser helped with the Western blots during his rotation period as a graduate student. 
 
R. R. Burgess is the principal investigator. 
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6.1 Summary 
The procedures for Western blots have been around for a long time and recent 
developments have increased the sensitivity for luminescent techniques so that the need of 
radioactive probes has been limited to only a few applications. Nevertheless most protocols 
require more than 6 hours and are often performed over more than a day. The majority of 
techniques require a secondary antibody conjugated to an enzyme that catalyzes a color 
reaction in order to amplify a detectable signal. However both processes, the binding of a 
secondary antibody and the catalyzed reaction with the dye, are sources for errors and the 
latter is disadvantageous for a signal that is linear over a larger range of detected antigen. In 
order to improve the procedure most commonly used for quantitative analysis and 
convenience, we investigated the use of fluorescence labeling of primary antibodies against 
E. coli RNA polymerase subunits (β', σE and σFecI) and their use in Western blots. We 
achieved a sensitivity (< 1 ng detectable protein) comparable to most luminescent techniques. 
Additionally we reduced the procedure time significantly to less than 1 hour after SDS PAGE 
and transfer to a membrane. Above all we obtained a linear signal over the range of 1 ng to 
1µg of protein making quantitative analysis of Western blots easier and more reliable. 
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6.2 Introduction 
Western blots are widely used to detect proteins in biological samples with very high 
sensitivity. The most common and established procedures for Western blots involve SDS-
PAGE to separate the proteins according to their size, a transfer to a membrane for 
immobilization and the use of two antibodies for their detection. The primary antibody 
specifically recognizes the protein of interest on the membrane. It is applied to the blot after it 
was blocked with either BSA or non-fat dry milk to saturate the membrane with protein to 
prevent unspecific binding of the antibody to the membrane. The secondary antibody (for 
example, goat anti-mouse IgG) recognizes the primary antibody according to its origin (for 
example mouse), since it generally binds to all immunoglobulins from the particular 
organism that the primary antibody was isolated from. The second antibody is typically 
conjugated with an enzyme catalyzing a reaction that turns a colorless compound into a 
detectable dye and can be used universally with compatible primary antibodies. Older 
procedures used radioactively-labeled secondary antibodies for sensitivity purposes (1), but 
recent developments make use of luminescent systems that reach similar performance 
without the disadvantages of working with radioactivity (2, 3). Both non-radioactive systems 
make use of an enzymatic reaction that amplifies the signal through a turnover of detectable 
substrates at the site of recognition. However this strategy poses a significant caveat for 
quantitative purposes, since it involves formation of a ternary complex at the recognized site 
and an amplification step through an enzymatic reaction. Both processes contribute to a 
potential variance of the signal created by a specific amount of sample. Additionally the 
linearity of the signal over an applicable range of sample amount is compromised especially 
by the amplification reaction (4). 
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In this work we describe an improved procedure for Western blots that can be 
performed in 1 hour or less after SDS-PAGE and transfer to the membrane. That not only 
results in a significantly shortened procedure, but also in an improved quantitative analysis 
with a linear range of detectable signal obtained from 1 ng to 1 µg of protein loaded on the 
initial SDS-PAGE gel. In order to achieve better reproducibility, signal-to-noise ratios and 
larger workable linear ranges for the quantitative use of Western blots, we investigated direct 
fluorescence labeling of the primary antibody. Fluorescence labeling of antibodies is 
commonly used procedure in fluorescence microscopy but surprisingly has not been used 
much in regular Western blot procedures. As a label, we used the cyanine dye IC5 as a bright 
fluorophore to achieve good sensitivity. Labeling was facilitated through a succinimide 
moiety linked to the dye, that reacts rapidly and selectively with lysine residues of the 
antibody in aqueous solutions under the conditions used. The fact that a secondary antibody 
and the addition of a substrate to develop the signal is no longer needed, significantly cuts 
down the time needed for this procedure, yet achieves limits of detection similar to most 
common luminescent techniques. 
 
6.3 Experimental procedures 
6.3.1 Materials and chemicals 
IC5-OSu was purchased from Dojindo Molecular Technologies, Inc. (Gaithersburg, 
MD, USA). Pre-casted 4-12% NuPAGE gels were purchased from Invitrogen. The MAbs 
NT73 (anti β'-subunit of core RNA polymerase), 1FE16 (anti σFecI) and 1RE53 (anti σE) 
used for labeling were produced in our lab as described elsewhere (6). Nitrocellulose 0.04 µm 
pore size was purchased from Schleicher&Schuell. All other chemicals were purchased from 
Sigma unless otherwise indicated in the text. Purified RNA polymerase was made as 
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described in Thompson et al. (7). Purified sigma factors were made as described in Anthony 
et al. (6). 
 
6.3.2 Buffers 
10x PBS buffer: 1.55 M NaCl, 10.6 mM KH2PO4, 29.6 mM Na2HPO4·7 H2O, pH 7.4; 
carbonate buffer: 1.7 g Na2CO3, 2.8 g NaHCO3 in 100 ml H2O at pH 9.5; Blotto: 1% (v/v) 
non-fat dry milk powder in PBS-buffer. 
 
6.3.3 Fluorescence labeling of antibodies 
The antibody was dialyzed into carbonate buffer. It is important to have no primary 
amines present in the buffer, that would otherwise react with the succinimide moiety of the 
dye inactivating it for the labeling reaction. The antibody solution was diluted with carbonate 
buffer to a concentration of 1 mg/ml. The procedure also works in PBS buffer although the 
labeling reaction is about 2-fold less efficient. The dye comes as a dry solid (IC5-OSu, MW= 
630.23 g/Mol, Dojindo) (Cy5 by Amersham or any other succinimide activated dye with the 
right fluorescence work as well). Succinimides are sensitive to moisture, since they can 
hydrolyze and thus lose their coupling activity. Therefore it is best to keep the dye as a solid 
under dry conditions. Avoid storage in aqueous or organic solvent. To save material, small 
portions of dye with a known amount should be prepared. 1 mg of IC5-OSu (Dojindo, 135 
US$) was dissolved in 1 ml of chloroform and divided into 10 aliquots of 100 µl each in 1.5 
ml Eppendorf vials. The chloroform is evaporated in a Speed Vac (5-10 minutes) and the 
vials are stored in sealed light-excluding bag at -20°C (a desiccation bag is helpful to keep 
moisture from inactivating the functional group of the dye, both come with the dye from the 
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manufacturer). These aliquots can be further divided to give 10 µg per aliquot, which is 
enough to label about 0.5 mg of antibody. One aliquot of 10 µg IC5-OSu was dissolved in 10 
µl DMSO (1.6 nmol/µl) and 2 µl (3.3 nmol) was added to 100 µl of NT73 MAb solution (1 
mg/ml; 0.66 nmol) to give a 5-fold ratio of IC5-OSu to antibody. While the reaction was 
incubated for 15 minutes at room temperature (24°C), a Pharmacia G-25 Sequencing column 
was equilibrated with the PBS buffer. Since carbonate buffered solutions are not stable, PBS 
buffer is preferred for later storage of the protein. This was done by washing the column 
twice with 500 µl of PBS buffer. The buffer was mixed with the resin in the spin columns and 
spun at 4000 rpm (do not exceed 2000 g !) for 30 seconds in the microfuge. The 100-µl 
labeling reaction was then loaded onto the resin and eluted by spinning at 4000 rpm for 30 
seconds. This was done to separate the labeled MAbs from the unbound IC5 label which can 
be seen as a blue residue left on the columns after the last spin. Spin columns with a G-25 
gel-filtration resin is used in place of dialysis, since it is more suitable for the small volumes 
down to 20 µl. We also observed very poor dialysis efficiency for the cyanine dyes. 
 
6.3.4 Evaluation of labeling efficiency (optional) 
10 µl of the resulting 100 µl blue solution, eluted from the column was diluted 20-fold 
with PBS buffer and the amount of protein and dye is determined spectrophotometrically 
(molar absorptivity of IgG: 206,000 M-1 cm-1 at 280 nm, molar absorptivity of IC5: 90,000 
M-1 cm-1 at 650 nm). From the measurements we calculated the molar ratio of the label with 
respect to the protein as well as amount of total label incorporated by the labeling reaction. 
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6.3.5 Use of IC5-labeled NT73 in a Western blot 
For SDS PAGE and subsequent wet blotting we used pre-casted 4-12% NuPAGE gels 
according to the manufacturers protocol. This involves a running time of 35 minutes for the 
SDS-PAGE at constant 200 V and a transfer for 1 hour at constant 200 A. The labeled 
antibody was used in the appropriate dilution (routinely 1:2000; up to 1:10,000 for testing) in 
20 ml Blotto. The blotted membrane (blocked with 1% Blotto for a minimum of 15 min and 
up to 2 days) was incubated for 5 to 60 minutes with the labeled primary antibody at room 
temperature. The blot was rinsed three times with 25 ml PBS buffer and scanned with a 
Storm Imager (Molecular Dynamics) in the red fluorescence scanning mode. For better 
background, longer washes (5 min each) can be made. 
 
6.3.6 Use of IC5-labeled anti-σE and anti-σFecI antibodies in quantitative Western blots 
We loaded known quantities of purified σE and σFecI on a pre-casted 4-12% 
NuPAGE gel. On the same gel we loaded a sample of crude extract from E. coli that was 
spiked with a known amount of the sigma factor, to determine whether we can verify its 
amount in our procedure. After wet blotting we labeled the antibodies 1RE53 (anti-σE) and 
1FE16 (anti-σFecI) and used them at a 1 to 4000 dilution in 20 ml 1% Blotto. The blotted 
membrane was blocked with 1% Blotto for 15 min and incubated with labeled primary 
antibody for 60 minutes at room temperature. The blot was rinsed three times with 25 ml PBS 
buffer for 5 min each and scanned with a Storm Imager (Molecular Dynamics) in the red 
fluorescence mode. 
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6.4 Results 
6.4.1 Labeling efficiency for IC5-labeling of antibodies 
We tested the labeled sample for labeling efficiency by measuring the absorbance of 
the labeled antibodies (according to manufacturer's information, the molar absorptivity of IC5 
at 650 nm is approximately 90,000 mol-1cm-1). The measured concentration was compared 
with the protein concentration measured by absorbance molar absorptivity of an IgG antibody 
at 280 nm is approximately 206,000 mol-1cm-1. Labeling efficiencies were roughly 2.5 mole 
dye per mole protein using a 5-fold molar ratio of IC5 dye to protein for the reaction. We 
have compared labeling efficiencies for 5 to 15-fold ratios of dye to protein and the results 
are shown in Figure 6.1. We observed maximum labeling efficiencies with up to 7-fold ratio 
of dye to antibody. Above that, decreased solubility led to a loss of protein (data not shown). 
Judging from the emission of the labeled protein and the free dye applying densitometry to 
the SDS gel, the remaining content of free dye was less than 5%. 
 
Figure 6.1: Labeling efficiency of MAb NT73 with IC5-OSu. 100 µg of NT73 in 100 µl was labeled with 
different ratios of IC5-OSu and the final ratio of dye-to-protein was measured by absorption at 280 and 
645 nm. Final dye-to-protein ratio increases to 5.5 up to a ratio of 9 of dye to NT73. From the total yield 
of protein, however, we saw a decrease of protein solubility starting at a a ratio of more than 7 (data not 
shown). 
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6.4.2 Performance of labeled antibodies in Western blot 
We tested the limit of detection for IC5-labeled NT73 in a Western blot. A pre-casted 
4-12% NuPAGE gel was loaded with a dilution series of 1 ng to 1 µg of purified RNA 
polymerase (0.4 to 400 ng of the β'-subunit). We probed the blot with 1-to-2000 diluted IC5-
labeled NT73 for 60 min and scanned the blot as described. We were able to detect a 
minimum of 0.4 ng of the β'-subunit (1 ng of RNA polymerase loaded). We also tested the 
linearity of the signal with respect to the loaded amount of protein and the signal intensity. A 
linear correlation between the loaded amount of protein and the obtained signal intensity in 
the Western blot was obtained from 30 to 400 ng. The results are summarized in Figure 6.2. 
 
Figure 6.2: Linearity and limit of detection of the β'-subunit of RNA polymerase in a Western blot with 
IC5-labeled NT73. The graphic shows the evaluation of a Western blot obtained after loading 1 ng to 1 µg 
of purified RNAP on a 4-12% NuPAGE gel, transfer onto a nitrocellulose membrane and incubation with 
IC5-labeled NT73 (2.5 final ratio of dye to protein, 1:2,000 dilution, 60 min incubation). The signal for the 
β'-subunit of RNA polymerase is visible down to 0.4 ng protein loaded on the SDS-PAGE gel (bottom 
right). Above each lane of the gel the amount of loaded β'-subunit is indicated in ng. However the signal 
increases linearly with respect to the amount of protein loaded from 30 ng up to the maximum of 400 ng 
loaded β'-subunit. A linear regression of the results in this interval gave a R-value of 0.99. 
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The procedure took about three hours from the time the SDS-gel was started to the 
time the image of the Western blot was taken and over half of that time was involved in 
electrophoresis and the transfer of the protein from gel to nitrocellulose membrane. 
 
6.4.3 Effect of incubation time and dilution of labeled antibody on quantification 
We repeated the experiment described above but this time we incubated the blot for 5, 
15, 30 and 60 min with 1-to-2000 diluted IC5-labeled NT73 and scanned the blot as 
described. We again tested the linearity of the signal with respect to the loaded amount of 
protein as well as the signal intensity. The signals increase roughly 10-fold as the incubation 
time is increased from 5 to 60 min although linearity doesn't seem to be compromised for 
shorter incubation times (see Figure 6.3).  
 
Figure 6.3: Effect of incubation time on the signal from IC5 in Western blots. The diagram shows the 
effect of incubation times at 1 to 2,000 dilution of with a final ratio of IC5 to NT73 of 2.5 which were 
varied at 5, 15, 30 and 60 minutes. The gel was loaded with purified RNA polymerase containing 31 to 417 
ng of β'-subunit. Regression of the results gave slightly different R-values for each different 
measurement. A significant increase in intensity can be observed with an increase of incubation time. 
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We also tested different dilutions (from 4000 to 10,000-fold) of labeled antibody with 
an incubation time of 60 min. Again there was no change in linearity but a change in intensity 
was observed (see Figure 6.4). The limit of detection was only slightly raised (from 0.5 ng to 
10 ng detectable β'-subunit) for a 10,000-fold dilution. 1 ng β'-subunit was still detectable 
with a 6000-fold dilution. It is important to note that 1 ng of the 156 kDa β'-subunit would be 
equivalent to 0.2 ng of a 30 kDa typically sized protein.  
 
Figure 6.4: Effect of dilution of IC5-labeled NT73 on the signal in Western blots. The diagram shows the 
effect of dilution factor at 60 minutes incubation with a final ratio of IC5 to NT73 of 2.5 which were 
varied at 1 to 4,000, 6,000, 8,000 and 10,000 dilution. The gel was loaded with purified RNA polymerase 
containing 31 to 400 ng of β'-subunit. Regression of the results gave a R-value of 0.99 for each dilution. A 
significant increase in intensity can be observed with an decrease of dilution of labeled antibody. 
 
 
6.4.4 Quantitative analysis of whole cell extracts 
We tested quantitative analysis of crude extracts with a known amount of sigma factor 
(σE and σFecI) added. We tested σE in the range of 10 to 100 ng and σFecI in the range of 
100 to 1000 ng of loaded protein. In both cases we obtained signal response linear over the 
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tested range of loaded protein as well as accuracy for the measured standards within the range 
(error of < 10%). The linearity and accuracy of the measurements with a whole cell extract 
matrix confirmed that we can detect and quantify the Western blots within the linear range of 
the assay. These results are summarized in Figure 6.5 and Figure 6.6. 
 
Figure 6.5: Use of IC5-labeled anti-σE antibody in a quantitative Western blot. The diagram shows the 
evaluation of a Western blot from a 4-12% polyacrylamide NuPAGE gel loaded with increasing amounts 
of σE (10, 25, 50 and 100 ng) as standards using the σE specific antibody 1RE53 labeled with IC5-OSu 
(1:1000 dilution, 60 min incubation). As samples for quantification, 50 and 75 ng σE were added two 
times each to a crude E. coli cell extract and loaded on the gel. This was done to validate the 
quantification in the presence of a typical sample matrix. The amounts protein obtained by the 
calibration line were 53 +/- 4 ng for the 50 ng sample loaded and 75 +/- 6 ng for the 75 ng sample loaded 
(vertical line down from the area reading obtained from the imaging indicate the sample data point). 
Thus these results were accurate within a margin of error of less than 10%. 
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Figure 6.6: Use of IC5-labeled anti-σFecI antibodies in a quantitative Western blot. The diagram shows 
the evaluation of a Western blot from a 4-12% polyacrylamide NuPAGE gel loaded with increasing 
amounts of σFecI (100, 250, 500 and 1000 ng) as standards using the σFecI specific antibody 1FE16 
labeled with IC5-OSu (1:1000 dilution, 60 min incubation). As samples for quantification, 500 ng σE were 
added four times each to a crude E. coli cell extract and loaded on the gel. The amount of protein 
obtained by the calibration line was 519 +/- 36 ng for the 500 ng sample loaded (vertical line down from 
the area reading obtained from the imaging indicate the sample data point) and was also accurate within 
a margin of error of less than 10%. 
 
6.5 Discussion 
The current methods for Western blots are well developed and highly sensitive non-
radioactive kits are available, that create signals with very high intensity that are easy to 
detect and evaluate. However it is still a challenge to get reliable quantitative data with these 
methods. The source for errors and loss of reproducibility can be found in many aspects of 
the classical procedure. The fact that a ternary complex of the blotted protein with primary 
and secondary antibody is necessary for detection is one aspect. Therein lies the intrinsic 
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problem, that the antibody has to recognize its antigen which was separated in a SDS PAGE 
under denaturing conditions and was bound to a membrane surface. Both processes can 
influence significantly the shape of the recognized epitope and therefore the efficiency of 
recognition by the antibody. Probably the greatest problem for quantification of Western 
blots is the amplification step achieved by a color or luminescence producing reaction. This is 
catalyzed by an enzyme which is linked to a secondary antibody that recognizes the primary 
antibody. The rate of this reaction is heavily dependent on the local concentration of the 
enzyme and the reactants, which can change during development and thus may cause a non-
linear response to varying amounts of antigen bound to the membrane. 
In order to circumvent the need for a secondary antibody and an amplification 
reaction, we decided to avail ourselves of very common fluorescence labeling procedures and 
detection systems in combination with the known Western blotting techniques. In contrast to 
common perception, fluorescence labeling of an antibody is a very simple and rapid 
procedure. Necessary reagents and methods are readily available and can be easily performed 
by anyone in a straight-forward procedure. Apart from the fact that the necessary labeling 
procedure can be performed within 15 minutes while the proteins are blotted to the 
membrane, it is also very cheap to label enough protein for 10 Western blots without the need 
for a conjugated secondary antibody and its substrates. The amount of 1 mg of dye can be 
used to label enough antibody for 500 to 5000 western blots depending on the dilution and 
volumes used for the incubation. Storage of labeled antibody was possible (after 1:1 dilution 
with 100% glycerol) over several months at -20°C without any observed loss of performance. 
However the use of different dyes, the amount of label per antibody or different antibodies 
may result in reduced solubility. We studied the labeling efficiency of NT73 with IC5-OSu in 
carbonate buffer at pH 9 and found similar results to those described in commercially 
available kits (CyDye, Ammersham). A 7-fold molar ratio of dye to antibody gave optimal 
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amounts of up to a final dye to antibody ratio of 5.5 without loss of protein due to decreased 
solubility. Incubation times with primary antibody were varied from 5 to 60 minute and 
although signal were linear over a similar range of antigen at lower incubation times, we 
observed a 10-fold increased signals for 60 minutes compared to 5 minutes incubation times. 
The degree of dilution had a similar effect of labeled antibody in the incubation step. Lower 
dilution led to increased signal without a significant effect on linearity. However optimization 
of the dilution factor may result in better specificity of the antibody and reduced the observed 
background. 
The fact that one can omit a wash step, an incubation step with a secondary antibody 
and the reaction for the development of the signal contributes to a significantly shortened 
procedure time as compared to most common procedures. Remarkably the procedure takes 
less than two hours from the point of time the gel was run, which takes only 35 minutes in 
case of the gels used, until the image of the Western blot is taken. In contrast to the most 
common procedures which allow the recording of the image by film exposure or simple 
photography, this procedure requires a fluorescence scanner like the one used in this study. It 
also has to be equipped with the right excitation source and acquisition filter. However this 
method of detection is superior in sensitivity and linearity over photography (5) and the 
equipment should be accessible in most biological institutes since it is used as a fluoroimager. 
It is also superior in workable range over film exposure, since film can be saturated easier 
than the detector of a fluorescence scanner. 
An important aspect in this study was the use of this procedure in quantitative analysis 
of Western blots. We tried to get a more linear response in the measured signal by a 
fluorescence labeled primary antibody, thus avoiding the use of a secondary antibody and the 
amplification reaction by its conjugated enzyme. We were able to show that the described 
procedure can be used for quantitative experiments with a large workable linear range (up to 
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3 orders of magnitude) within a margin of error of less than 10%. However, we observed that 
it is necessary to run the standard samples used for calibration on the same gel and blot in 
order to obtain reliable results, probably since transfer efficiency, sample conditions and 
backgrounds can vary significantly from one preparation to another. Obviously this limits the 
number of samples that can be analyzed in one blot. It is also important to note that different 
antibodies vary in their binding efficiency, so it is necessary to check each antibody for its 
performance with purified antigen in the assay first. Still the simplification of the procedure 
to just one incubation step with only one antibody with one less washing step should increase 
the performance of antibodies with weaker affinities. Since we tested the described procedure 
with three different antibodies, we are confident that this method is not limited to just a few 
antibodies. Overall we believe that due to its increased simplicity, increased performance, 
reduction of procedure time to less than three hours for quantitative procedures and lower 
than 2 hours for qualitative measurements including the SDS PAGE, and less material 
expenses, this work describes a valid improvement of the common procedure. 
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Chapter 7 
 
Conclusion and Future Directions 
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7.1 Initial proposal 
The primary goal of this thesis was to develop an assay for sigma-core binding of 
bacterial RNA polymerase based on LRET and demonstrate its use for biochemical 
characterization and drug discovery. The investigations started on the basis of the results 
published by T. Arthur (1-3) from this lab who characterized the key binding region between 
σ70 and core RNA polymerase from E. coli. The project was inspired by the work from T. 
Heyduk (4) who established the use of LRET to study protein-DNA interactions in the 
transcription machinery of E. coli. The prospect of a homogeneous binding assay for sigma 
and core that could be performed in microwell plates raised the possibility of its application 
in both basic biochemical research and drug discovery. The latter was supported by in vivo 
studies that showed an inhibitory effect of the coiled-coil from the β'-fragment that binds to 
σ70 on cell growth of E. coli (1). 
 
7.2 Chapter 2 
In order to convert the available LRET-procedures into the assay presented in this 
work the major challenges encountered were connected to fluorescence labeling techniques. 
Since LRET can occur at fluorophore concentrations above 200 nM by diffusion it is crucial 
for the performance of the assay to purify the labeled proteins from free dye. A new on-
column fluorescence labeling procedure described in Chapter 2 using Ni-NTA and anion 
exchange resins (5) was a key breakthrough in the development of the LRET assay. 
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7.3 Chapter 3 
The reduced solubility of some labeled proteins tested in the beginning led to the use 
of the more stable β'-fragment(100-309). Further improvements with respect to intrinsic 
requirements for assays used in high-throughput screening were developed and are subject of 
Chapter 3. For example storage conditions, that can sustain the stability of the labeled 
proteins up to 24 hours, depending on the size of the screened compound library. Therefore 
storage under denaturing conditions and refolding through dilution directly into the assay 
were established for the assay. Finally a very small library of 100 natural product extracts 
were used to test the assay under conditions encountered in screening. The undefined nature 
of the library challenged the performance of the LRET assay through a high intrinsic 
background. However an active sample was identified in the screen and confirmed for its 
inhibition of enzyme activity by in vitro transcription. The purification of the active 
component has recently started in collaboration with Prof. Tanaka, who provided the library. 
This hit encourages future efforts for an extensive screening for an inhibitor of RNA 
polymerase and possibly a new class of antibiotics. The use of this assay in an automated 
high-throughput screen of two libraries containing 16,000 and 65,000 purified compounds 
has not been performed because the completion of a screening facility here at the University 
of Wisconsin was significantly delayed.  
 
7.4 Chapter 4 
This part of the thesis extends the applications of the LRET assay by the use of 
randomly labeled full-length core RNA polymerase and other sigma factors and a new pair of 
dyes (IC3 and cs124-DTPA-Phe *Tb). In this study we gained preliminary results for the 
determination of binding constants for the interaction of sigma factors and core RNA 
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polymerase. The obtained values for Kdiss of σ70 and σ32 were in good agreement with the 
best of the previously published data and can serve as a good basis for more comprehensive 
binding studies of all sigma factors and other binding partners of RNA polymerase from E. 
coli. 
 
7.5 Chapter 5 
In addition to the binding studies focused on in this thesis, the expertise of this lab in 
making MAbs and using polyol responsive MAbs for rapid and gentle immunoaffinity 
purification of proteins was taken as an opportunity to learn these techniques and apply them 
in a broader context of this thesis. The isolation of the MAb 8RB13 and its use to purify core 
RNA polymerase from different species is presented in Chapter 5. The antibody will prove to 
be very useful for the purification of RNA polymerase from other prokaryotes, especially 
from problematic pathogens, to test the activity of inhibitors identified by the LRET assay. 
 
7.6 Chapter 6 
The experience with fluorescence labeling techniques that was gained through the 
LRET studies led to the development of an improved quantitative Western blot procedure 
described in Chapter 6.  
 
7.7 Appendix 
The methods developed for the studies described in Chapter 2 and 3 were summarized 
for an invited publication in Methods in Enzymology (6) and are attached to this thesis as an 
Appendix. 
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Studying Sigma-Core Interactions in Escherichia coli RNA Polymerase by 
Electrophoretic Mobility Shift Assays and LRET 
 
 
 
 
The manuscript presented in the Appendix has been solicited for publication as: 
Bergendahl, V., and Burgess, R. R. (publication expected in 2003), Studying Sigma-Core 
Interactions in Escherichia coli RNA Polymerase by Electrophoretic Mobility Shift Assays 
and LRET. Methods Enzymol 
 
My contributions are that I performed all the experiments and wrote the manuscript. 
 
R. R. Burgess is the principal investigator. 
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A.1 Introduction to protein binding studies 
There is great interest in identifying and characterizing protein-protein interactions. 
Many biological processes such as cell signaling, metabolism, enzymatic activity and 
specificity are controlled by modulation of protein structure and function upon binding to 
another protein. Transcriptional regulation, for example, is mediated significantly by protein-
protein interaction because binding of transcription factors to RNA polymerase confers its 
specificity for promoters of transcribed genes. We would like to use the transcription 
machinery from E. coli in particular, to illustrate two very useful strategies to investigate 
protein binding. Our work focuses on the interaction of the main transcription factor σ70 with 
core RNA polymerase (RNAP). Their major interaction interface is part of region 2.1 to 2.2 
(residues 360-421) in σ70 and a coiled-coil at residues 260-309 in the β'-subunit of RNAP (1-
3). 
There are many approaches to studying protein-protein interactions. Here we have 
chosen to describe electrophoretic mobility shift (EMS) assays and fluorescence resonance 
energy transfer (FRET) for several reasons. EMS assays are fairly simple and quick to 
perform with the equipment present in most biologically oriented labs. At the same time they 
can give useful initial information about a protein binding to another protein, DNA or RNA. 
EMS assays are based on the change of mobility of a protein during polyacrylamide gel 
electrophoresis (PAGE) upon binding to DNA, RNA or another protein. Since binding of a 
protein to its binding partner predominantly requires that its higher order structure is intact, 
non-denaturing or native gels are used. Crucial to EMS assays is the fact that the procedure 
involves separating the complex from the unbound binding partner by size and charge 
differences. This changes the equilibrium conditions at which initial binding occurs and thus 
weak interactions, i.e. in complexes that have a half life shorter than the time scale of the 
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separation step, are underrepresented or cannot be detected since the interaction doesn't 
persist throughout the procedure. This is true for all non-homogenous techniques like surface 
plasmon resonance (SPR, used in BIAcore instruments), co-immunoprecipitation or "pull-
down" assays, ELISA assays, Far-Western blotting, size exclusion and affinity 
chromatography, as well as sucrose gradient centrifugation. 
In a homogeneous binding assay, i.e. all components of the assay are free in solution 
and no separation steps are used. A key benefit of such an assay is that the binding 
measurement is done without perturbing the binding equilibrium. This often allows more 
accurate assessment of the binding forces and mechanisms, thus resulting in most cases in the 
superior although more technically more demanding way of investigating binding. The most 
common techniques involve spectroscopic methods because the use of light as a probe doesn't 
change the conditions in most systems. These methods use NMR, light scattering, and very 
often fluorescent probes like in fluorescence polarization (FP) and FRET assays. Recent 
developments of FRET also allow analysis of protein-protein interactions in vivo (4). 
Together with two-hybrid screens and functional assays these are currently the only 
established methods to obtain reliable in vivo data. 
In a FRET-based assay, the binding partners have to be labeled with two different 
fluorophores. In order to allow resonance energy transfer between the two, the emission 
spectrum of the fluorophore serving as a donor has to overlap sufficiently with the excitation 
spectrum of the other fluorophore serving as the acceptor. Resonance (i.e. acceptor frequency 
equals donor frequency) facilitates a radiationsless energy transfer through dipole-dipole 
interactions. As described by the Förster Theory (5), the amount of transferred energy decays 
with the inverse sixth power of the distance between the dyes. The intensities of the donor or 
the acceptor emission can therefore give information about the distance of the two dyes and 
ultimately tell whether the labeled proteins are bound to each other. 
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We decided to focus on LRET (Luminescence Resonance Energy Transfer)-based 
assays for a homogenous assay to measure the formation of the σ70-β'-complex. LRET is a 
recent modification of FRET (6-9) that uses a lanthanide-based donor fluorophore. The more 
general term luminescence instead of fluorescence (as in FRET) indicates that lanthanide 
emission is technically not fluorescence (i.e., arising from a singlet to singlet transition). Its 
most characteristic property is a very long fluorescent lifetime of up to several milliseconds, 
compared to the short lifetime of most organic-based fluorophores in FRET (picoseconds up 
to a microsecond). The conventional dipole-dipole theory of Förster is still applicable for 
LRET, so that energy transfer from a lanthanide donor to an generally short lived 
(nanoseconds) acceptor fluorophore results in its prolonged emission (milliseconds). 
We labeled σ70 with a Europium-DTPA-AMCA complex as a donor and the β'-
fragment with IC5-PE-maleimide. Since fluorescence detection is usually very sensitive, the 
labeled proteins can also be used very efficiently for their detection in gels resulting from 
EMS assays, avoiding the need for other labeling methods like 32P-labeling. 
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A.2 Introduction to fluorescence labeling of proteins 
For uniform labeling of proteins with only one fluorophore we exploited the specific 
reaction of maleimide-linked dyes with cysteine residues in proteins with only one cysteine 
residue. The maleimide moiety of the dye reacts readily in sulfhydryl-free buffers and is 
highly specific to cysteine residues at pH-values between 6.5 and 8. If uniform labeling is not 
critical, succinimide derivatives of the dyes can be used to randomly label lysine residues in 
amine-free buffers at pH 7.5 to 9.0. In our studies we have addressed a few challenges in 
fluorescence labeling of proteins. For example oligomerization and oxidation of the sample 
can lead to a significant loss of labeling, so that a reduction step before derivatization can 
increase yields. Unfortunately reducing agents such as 2-mercaptoethanol (2-ME) and Tris(2-
carboxyethyl)phosphine (TCEP) have to be removed before the labeling reaction, since they 
inhibit maleimide labeling (10). Another challenge when labeling proteins is the separation of 
labeled product from the excess dye. This is especially important for samples used in FRET 
and LRET assays, since too much free dye can cause additional signal by diffusion-controlled 
resonance energy transfer when working at free dye concentrations above 200 nM. For 
cyanine dyes like IC5 it is very difficult to remove excess dye by dialysis and it usually 
requires an extra gel filtration step. 
Here we describe a procedure for purification and labeling where reduction, labeling 
and washing away excess dye is carried out, while the protein is bound to the column. 
Additional information about the labeling procedures presented here can be found in 
Bergendahl et al. (11). In case of the hexahistidine-tagged beta prime (RpoC) fragment 
(residues 100-309), that has a single naturally-occurring cysteine at residue 198, we worked 
on a Ni-NTA column. We purified and labeled a single cysteine σ70 mutant (C132S, C291S, 
C295S, S442C)(12) on a DE-52 anion exchange column. To circumvent reducing the Ni-
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resin by 2-ME we used TCEP instead. After reduction, TCEP was washed away and the on-
column derivatization was carried out immediately to avoid oxidation. Excess dye could be 
washed from the column while the labeled product remained bound to the resin. 
 
Below we present the following protocols: 
1. Ni-NTA Purification and Labeling of HMK-His6-β'(100-309) 
2. DE52 Purification and DTPA-AMCA-Europium Derivatization of σ70(S442C) 
3. Electrophoretic Mobility Shift (EMS) Assay for Complex Formation of 
Labeled σ70 
and β'-Fragment 
4. LRET Assay for Protein-Protein Interaction of Labeled σ70 and β'-Fragment 
 
All chromatographic procedures were carried out by gravity flow at room 
temperature. The assays described in 3. and 4. can be performed with native labeled proteins 
or with denatured proteins directly added into the reaction mixture, which by dilution of 
GuHCl in the final assay allowed instant refolding. This can be done to prevent precipitation 
of the refolded labeled protein upon storage before the assay. In order to assure that refolding 
occurs and to confirm the results from the experiments with denatured protein being added, 
controls with native or refolded proteins should be carried out. 
 
A.3 Materials and chemicals 
 IC5-PE-maleimide was purchased from Dojindo Molecular Technologies, Inc. 
(Gaithersburg, MD). DTPA-AMCA-maleimide was produced as described by T. Heyduk. 
(12) (CAS numbers of the used starting materials: DTPA-anhydride: 23911-26-4, Maleimido-
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propionic acid, NHS ester: 55750-62-4, AMCA: 106562-32-7). These so-called Selvin-
chelates for Europium are being made commercially available by PanVera (Madison, WI). 
Other Europium-labels are sold by Packard. Any of these labels should work in these 
protocols as long as they contain the maleimide group for derivatization. Disposable columns 
(10 ml PolyPrep, 0.8x4 cm) were purchased from BioRad. Ni-NTA resin was purchased from 
Qiagen (Hilden, Germany). TCEP and TritonX-100 were purchased from Pierce. EuCl3 and 
all other chemicals were purchased from Sigma unless otherwise indicated in the text. Pre-
cast NuPAGE PAGE-gels were purchased from Invitrogen. A multi-plate reader (Wallac, 
VictorV2 1420) was used to perform the LRET assays. 
 
A.4 Buffers and solutions 
Native PAGE buffer: 200 mM Tris-HCl pH 7.5, 20% glycerol, 0.005% bromphenol 
blue; NTG buffer: 50 mM NaCl, 50 mM Tris, 5% glycerol; pH 7.9; TGE buffer: 50 mM Tris-
HCl, pH 7.5, 5 % glycerol, 0.1 mM EDTA; NTTw buffer: 500 mM NaCl, 50 mM Tris-HCl 
pH 7.9, 0.1 % (v/v) Tween20; NTGED buffer: 50 mM NaCl, 50 mM Tris-HCl, pH 7.5, 5 % 
glycerol, 0.1 mM EDTA, 0.1 mM DTT; storage buffer: 0.2 M NaCl, 50 mM Tris-HCl pH 7.5, 
50% glycerol, 0.1 mM EDTA, 0.1 mM DTT 
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A.5 Ni-NTA purification and labeling of HMK-His6-β'(100-309) 
A.5.1 Overproduction of HMK-His6-β'(100-309) and Purification of Inclusion Bodies. 
HMK-His6-β'(100-309) was overproduced in E. coli BL21(DE3) from pTA133 (10) 
and is a chimera (25 kDa) with the amino acid sequence MARRASVHHHHHHM N-
terminally fused to β'(100-309). The underlined sequence represents a heart muscle kinase 
(HMK) recognition site and was used in the original construct to allow 32P-labeling of the 
protein, but we did not make use of it in this paper. The cells were grown in Luria Broth (LB) 
at 37°C, induced for 2 hours with 0.5 mM IPTG, harvested and lysed. Inclusion bodies were 
isolated and washed in 10 ml NTGED-buffer + 0.1% (v/v) TritonX-100. Washed inclusion 
bodies were stored in aliquots at -20 °C until use. 
 
A.5.2 Procedure 
1. One aliquot of about 20 mg (wet weight, from 100 ml of culture) of β' inclusion bodies is 
solubilized in 1.5 ml NTTw-buffer + 6 M GuHCl + 5 mM imidazole. 
2. The precipitate from the solubilized inclusion bodies is spun down in a microfuge at 
18,000 g (14,000 rpm) for 5 min. 
3. The supernatant is loaded on a BioRad column (10 ml PolyPrep, 0.8x4 cm) containing 0.5 
ml Ni-NTA matrix (Qiagen) that has been equilibrated with 5 ml NTTw-buffer + 6 M GuHCl 
+ 5 mM imidazole. That way the column is saturated with approximately 5 mg of the target 
protein. 
4. The column is washed with 5 ml NTTw-buffer + 6 M GuHCl + 20 mM imidazole to 
remove unbound protein. 
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5. To reduce any disulfide bonds, the column is washed with 5 ml of freshly prepared NTTw-
buffer + 6 M GuHCl + 20 mM imidazole and 2 mM TCEP. 
6. Excess TCEP is removed by washing with 3 ml NTTw-buffer + 6 M GuHCl + 20 mM 
imidazole. 
7. The bound protein is derivatized with IC5-maleimide by loading 2 ml freshly prepared 
NTTw-buffer + 6 M GuHCl + 20 mM imidazole and 0.1 mM IC5-PE-maleimide. 
8. The flow-through is reloaded onto the column twice before excess dye is removed by 
washing with 3 ml NTTw-buffer + 6 M GuHCl + 20 mM imidazole. 
9. The derivatized protein is refolded while column-bound by washing with 3 ml NTTw-
buffer + 20 mM imidazole to wash away the denaturant GuHCl. 
10. Derivatized protein is eluted with NTTw-buffer + 200 mM imidazole, dialyzed into 
storage buffer and stored at -20°C at concentrations of around 0.5 mg/ml. 
 
A.5.3 Comments 
The procedure can be done under denaturing conditions throughout, eluting the 
labeled protein denatured. Another option is to load the protein onto the Ni-NTA-resin after 
refolding the β'-fragment into a 65-fold excess of TGE-buffer. A third variation is to refold 
the β'-fragment on the column just before labeling with the dye. TCEP is used as a reducing 
agent because it doesn't interfere with the Ni-NTA resin like 2-ME. TCEP is an odorless 
white powder that can be added as a solid just before use. It dissolves readily in aqueous 
solutions and is very stable unless chelators like EDTA are present. IC5-PE-maleimide is 
dissolved in chloroform and divided into aliquots of 0.1 micromole. The aliquots were then 
dried down in a SpeedVac (SpeedVac SVC100H, Savant Instruments, Farmingdale, NY). 
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The use of water is not recommended as it may cause hydrolysis of the maleimide moiety 
over time, especially upon storage. 
 
A.6 DE52 purification and DTPA-AMCA-europium derivatization of σ70(S442C) 
Purification and derivatization of σ70 is done after refolding and in a similar fashion 
as the β'-procedure, this time using Whatman DE52 resin instead of the Ni-NTA agarose and 
using TGE-buffer instead of NTTw-buffer: 
 
A.6.1 Overproduction of σ70 (S442C) and purification of inclusion bodies 
Sigma70(442C) is overproduced from a plasmid derived from the σ70-expression 
system pGEMD (13, 14) that had a HindIII fragment containing the rpoD gene from E. coli 
cloned into a pGEMX-1 (Promega) vector. The cells were grown, induced, harvested and 
lysed. Inclusion bodies were isolated and washed in 10 ml NTGED-buffer + 0.1% (v/v) 
TritonX-100. Washed inclusion bodies were frozen in aliquots at -20 °C until use. 
 
A.6.2 Procedure 
1. One aliquot of about 20 mg (wet weight, from 100 ml of culture) of σ70 inclusion bodies 
are solubilized in 5 ml TGE-buffer + 6 M GuHCl. 
2. To refold proteins, the denaturant is diluted 100-fold by dripping into 500 ml of chilled 
TGE-buffer + 0.01% TritonX-100 slowly stirring on ice. If precipitation occurred, the 
precipitate is removed by centrifugation at 25,000 g (15,000 rpm, SS-34 rotor) for 15 min at 
4°C. 
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3. The soluble refolded protein is then bound to an anion exchange resin by adding 1 g DE52 
(Whatman) dry resin as a suspension in 5 ml TGE-buffer + 0.01% TritonX-100 directly into 
the 500 ml of diluted, renatured protein. 
4. After stirring slowly for 15 min, the suspension is poured into an empty 25 ml Econo-Pack 
column (BioRad) and washed with 5 ml NTG-buffer + 0.01% TritonX-100. 
5. 5 ml NTG-buffer + 2 mM TCEP + 0.01% TritonX-100 is loaded onto the column to reduce 
any disulfides formed by dimerization of sigma. 
6. The column is washed with 5 ml NTG-buffer + 0.01% TritonX-100 to remove TCEP. 
7. To label σ70, 1 ml NTG-buffer + 0.01% TritonX-100 + 1 mM DTPA-AMCA is loaded 
onto the resin and flow-through is reloaded onto the column 2 times to ensure maximum 
labeling. 
8. The Europium-complex is formed by loading 5 ml NTG-buffer + 0.01% TritonX-100 + 1 
mM EuCl3 onto the resin containing the derivatized protein. (Phosphate buffers should be 
avoided when working with lanthanides since insoluble complexes can lead to undesired 
precipitation.) 
9. The column is washed with 5 ml NTG-buffer + 0.01% TritonX-100. 
10. Labeled protein is eluted with TGE-buffer + 500 mM NaCl. The eluted fractions are 
analyzed by SDS-PAGE and pooled according to their purity and protein content. 
11. The fractions of labeled σ70 are pooled and brought up to 50% glycerol or dialyzed 
against storage buffer (final protein concentration is about 2 mg/ml). The labeled protein is 
stored at -20°C until use. 
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A.6.3 Comments 
Labeling can also be done after purification by adding the purified protein to an 
aliquot of the dye (same buffers and conditions). That way samples of 10-100 µl can be 
labeled. Excess label and Eu-ions are then removed either by dialysis or by using a Pharmacia 
G50 spin-column. A SDS-gel of a typical purification is shown in Figure A7.1. 
 
 
Figure A7.1: SDS-PAGE gel of the β'-purification and derivatization steps. The fluorescence scan of a gel 
with samples taken after each step throughout the procedure illustrates the purification of the β'-
fragment (refolding after fluorescence labeling). The labeling above the lanes represent the step numbers 
in the procedure at which the samples were taken. Purification from minor impurities can be observed as 
well as very low elution of the β'-fragment at any time except for the fractions 1 to 3 eluted with 200 mM 
imidazole. The IC5-scan was performed with a Molecular Dynamics Storm system in the red fluorescence 
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mode and thus shows the IC5-labeled proteins. The gel was scanned before staining with Coomassie blue. 
Note the low level of free label in the eluted fractions. 
 
A.7 Electrophoretic Mobility Shift (EMS) assay with labeled σ70 and β'-fragment 
For the performance of an EMS assay it is important to use the appropriate buffer 
conditions. Salt concentration has to be chosen wisely, since some protein-protein 
interactions are sensitive to high salt. The pH of the buffer has to be chosen according to the 
pI of the proteins. Since the sample buffer and the native gel contain no SDS, which confers 
the proteins with the negative charges, the proteins themselves have to have a negative charge 
in order to migrate into the gel during electrophoresis. Most sequence analysis software 
allows an estimate of the pI of a protein and even the net charge at a given pH. The EMS 
assays were performed in a total volume of 20 µl. The buffer conditions are 5% glycerol, 50 
mM Tris-HCl, pH 8.8, 50 mM NaCl, bromphenol blue 0.005% (w/v). Standard final protein 
concentrations were 250 nM of σ70 (Eu-chelate labeled protein) and 0.1 to 2 µM β'-fragment 
(IC5-labeled protein). Concentrations can be lowered to 10 nM. While the detection limit of 
the Coomassie blue stain is reached at these concentrations, the fluorescence scan still gives 
good readouts. 
 
A.7.1 Procedure 
1. Labeled σ70 is added to the appropriate amount of water and 5 µL of Native PAGE buffer 
(to result in a final volume of 20 µL after all components are added). 
2. For competition experiments unlabeled β'-fragment is added. 
3. Labeled β'-fragment is added last. 
4. The mixture is incubated for 5 min at room temperature. 
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5. 15 µl is loaded on a pre-cast native PAGE-gel (12-well, 12% polyacrylamide, 
Tris/glycine). 
6. The gel is run at constant 120 V in the cold room at 4°C for 4 hours. 
 
A.7.2 Comments 
The concentration of the added components should be adjusted by dilution, so that the 
added volume does not exceed 2 µl. That way mixing and final concentrations are not varied 
much by the addition of each component. The solutions have to be mixed well after addition 
of each component by pipetting. This is especially important to allow good refolding when 
denatured proteins are added. The electrophoresis should be run with pre-chilled buffers, gels 
and apparatus in the cold room (4°C) at constant voltage of 120 V (5-20 mA, variable). In 
some cases running the gel at 4°C might not be crucial but in our case it increased observable 
complex significantly. Running times may vary according to the charge and therefore the 
mobility of the proteins. In our case running at 2-4 hours gave best results in terms of 
separation and sensitivity. The IC5-emission was scanned on a Storm system (Molecular 
Dynamics) in the red fluorescence mode. The Europium emission can be scanned by using an 
Fotodyne UV light box (λexcit.= 312 nm) with 6 seconds acquisition time and the common 
filter for scanning ethidium bromide-stained gels. Total protein was stained with Coomassie 
blue stain using the Gel Code staining solution (Pierce) according to the procedure of the 
manufacturer and scanned with a Hewlett Packard flat bed scanner (ScanJet 6200C). For a 
typical gel from a EMS assay see Figure A7.2. We have also successfully used EMS assays 
with core RNA polymerase to investigate sigma binding. Since in the native gel multiple 
bands arise from core due to oligomerization, it is recommended to use only the σ70 in the 
labeled form and core RNA polymerase unlabeled. 
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Figure A7.2: The result of an EMS assay. The three pictures of the same gel taken by different staining 
and scanning techniques show increasing amounts of labeled β'-fragment (0, 50, 100, 250 nM) that can 
shift the labeled σ70 (250 nM) into the upper band. In the five lanes to the right unlabeled β'-fragment 
(100, 250, 500, 750, 1000 nM) was added to compete with the IC5-labeled β'-fragment for Eu-labeled σ70 
which were kept at a constant concentration in a ratio of 1:1 (250 nM). The upper frame shows the 
Coomassie-stained gel. Labeled σ70 shows up in the lower band and the complex in the top band. The 
extra band above the complex arises from σ70 dimers linked by a disulfide bond which prevented their 
fluorescence labeling. The middle frame represents the same gel, but was acquired before Coomassie 
staining with a UV-box and an orange filter on the camera that can only visualize the Eu-emission due to 
the excitation wavelength (312 nm). It confirms that both bands contain Eu-labeled σ70. The bottom 
frame of the same gel, was taken with a Storm imager (Molecular Dynamics) that can only visualize the 
IC5-label. It confirms that only the upper band contains labeled β'-fragment. The free β'-fragment runs 
as a diffuse band barely migrating into the gel. The unlabeled β'-fragment can clearly compete for the 
labeled σ. 
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A.8 LRET assay for protein-protein interaction of labeled σ70 and β'-fragment 
The format of the assay presented here was first designed to be suitable for high 
throughput screening for inhibitors of the protein-protein interaction. Thus it is robust, quick 
to perform and can give useful initial data about binding, although the use of a screening 
device like the multiwell plate reader does not fully exploit the potential of LRET. Much 
higher accuracy and sensitivity can be achieved by the use of a suitably equipped fluorimeter 
like the one described in Heyduk et. al. (15). Furthermore such a setup allows accurate 
measurement of the distance between the dyes, which in case of allosteric binding can give 
valuable information about mechanistic details. Nevertheless the cost, operation and the 
access to such instruments is much more demanding compared to plate readers. 
The assay was performed in a total volume of 200 µl in NTG-buffer (plus 2.5% 
DMSO when library samples were used) with typical concentrations of 10 to 100 nM labeled 
protein. It is very important to keep salt concentrations constant, since many protein-protein 
interactions are salt dependent. Therefore amounts of salt added with the proteins and 
samples should be corrected for when adding NaCl to give the final concentration of 50 mM. 
Stock solutions (200 nM) of σ70 was prepared prior to the assay by dilution with NTG of 
labeled protein (40 µM) that was stored at -20°C in storage buffer. Since the labeled β'-
fragment shows a tendency to aggregate upon storage, we preferred to store it denatured in 6 
M GuHCl and refolded it by dilution into the assay. A stock solution (1.25 µM) of the β'-
fragment was prepared by 10-fold dilution of labeled denatured protein (stored at 75 µM in 
NTTw-buffer containing 6 M GuHCl) with 6 M GuHCl and 6-fold dilution to 1 M GuHCl 
with NTG. First, 10 µl of the σ70-stock solution was mixed with NTG buffer (amount 
adjusted to give a final volume of 200 µl), then the potential inhibitor (5 µl in DMSO), salt or 
solvent was added and finally the 5 µl of denatured labeled β'-stock solution was added. 
 132
Mixing (pipetting up and down three times) after addition of each component was very 
important for reproducible results. The mixture was incubated for 30 min at room 
temperature and measured in a 96-well plate (Costar 3650) with a multi-plate reader (Wallac, 
VictorV2 1420). For this time-resolved fluorescence measurement, the manufacturer's 
protocol (LANCE high count 615/665) was used (excitation was with 1000 flashes at 325 
nm; measurement was delayed by 50 µs and data acquired for 100 µs at 615 and 665 nm). 
The time for one measurement cycle was set for 1000 µs. 
 
A.8.1 Procedure 
1. The appropriate amount of 500 mM NaCl, 500 mM Tris HCl pH 7.9, 50% glycerol and 
H2O are mixed to result in the final concentrations 50 mM NaCl, 50 mM Tris HCl pH 7.9, 
5% glycerol and 200 µl total volume after samples and proteins have been added. 
2. 1-10 picomoles of labeled σ70 (10-100 nM final concentration) is added in a 10 µl volume. 
3. For competition or inhibition experiments, unlabeled proteins or samples are added. 
4. 5-20 picomoles labeled β'-fragment is added. 
5. The mixture is incubated for 30 min at room temperature. 
6. Samples are read in the multi-plate reader (Wallac, VictorV2 1420) with a TR-LRET 
protocol (here: LANCE high count 615/665). 
 
Typical results from a LRET measurement showing salt dependence of binding are 
shown in Figure A7.3. 
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Figure A7.3: Dependence of binding on NaCl concentration in the LRET-assay. With increasing amounts 
of salt, the LRET-signal significantly decreases due to the decreased amount of σ70/β'-complex formed. 
The assay was performed in the fashion described in the text with the following protein concentrations: 
20 nM Eu-labeled σ70, 40 nM IC5-labeled β'-fragment. 
 
A.8.2 Comments and Variations 
Without going into detail we would like to point out that for controlled labeling of the 
target protein, alternative methods can be used. Site-specific protein lableling using 
biarsenical componds is described in Gaietta et al. (16). The Terbium donor and its 
compatible biarsenic compound FIAsH-EDT2 are available from PanVera. Site-specific 
intein-mediated C-terminal 5-(L-cysteinylamido-acetamido)-fluorescein (Cys-F) labeling 
which can be used in combination with Terbium chelates as donors is described in Mekler et 
al. (17) and Tolbert et al. (18), respectively. For most of the experiments it is actually not 
necessary to label the proteins at defined positions. This is only necessary for measurements 
determining the distance between the fluorescent probes. For general binding studies, random 
labeling of lysine residues using succinimidyl ester or isothiocyanides of the acceptor is 
absolutely sufficient. We have successfully labeled core RNA polymerase with IC5-OSu 
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while it was bound to a DE52 column and used it in LRET assays with this strategy. Since 
lysine residues are very abundant on most protein surfaces, random labeling with a 3 to 5-fold 
molar ratio of label to protein resulted in protein mostly active in binding. The molecules that 
are inactivated through labeling can be neglected since they cannot create signal in the LRET 
assay. Thus a loss of binding activity has to be corrected for when looking at quantitative 
results. This approach has the advantage that the target protein doesn't have to be mutated to a 
single cysteine variant, which would still have to have its activity confirmed. Generally any 
protein could be studied this way by labeling it in its purified form. Therefore the calculated 
amount of a 3 to 5-fold molar ratio dye to protein (1 mg protein in 100 µl) is added either 
dissolved in DMSO or water. The reaction time is usually not more than 15 min at room 
temperature. Unbound label can be removed afterwards by dialysis. In the case of very 
"sticky" dyes, like cyanine dyes, spin columns (Pharmacia) are more efficient. 
In the same way a specific antibody can be labeled. It can then be used for indirect 
labeling of its antigen and measured with the fluorescence labeled antigen's binding partner in 
a time-resolved LRET experiment. Our experiments show comparable results with this 
approach, although it is critical to keep the concentration of labeled antibodies below the 
antigen concentration, otherwise the addition of "unlabeled" antigen in competition 
experiments will increase the signal until the antigen is in excess. It is obvious that in screens 
for inhibitors of a protein-protein interaction of interest, compounds that interfere with the 
antibody-antigen interaction would show up as false positives. 
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2-ME 2-mercaptoethanol 
ATCC american type culture collection 
Aλ absorption at the wavelength λ [nm] 
bp base pairs 
DMSO dimethylsulfoxide 
DTE 1,4-Dithioerythritol 
DTPA-AMCA diethylenetriaminepentateic acid-7-amino-4-methylcoumarin-3-
acetic acid 
DTT dithiothreitol 
EDTA Ethylendiamintetraessigsäure 
ELISA enzyme-linked immunoabsorbent assay 
EMS electrophoretic mobility shift 
EtOH Ethanol 
FRET fluorescence resonance energy transfer 
GuHCl guanidinium hydrochloride 
HMK  heart-muscle kinase 
HTS high-throughput screening 
IMAC immobilized methal affinity chromatography 
IPTG isopropyl β-D-thiogalactoside 
LRET luminescence resonance energy transfer 
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v/v volume per volume 
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